<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7865227</article-id><article-id pub-id-type="pmid">33530389</article-id><article-id pub-id-type="doi">10.3390/molecules26030631</article-id><article-id pub-id-type="publisher-id">molecules-26-00631</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><italic>Pulmonaria obscura</italic> and <italic>Pulmonaria officinalis</italic> Extracts as Mitigators of Peroxynitrite-Induced Oxidative Stress and Cyclooxygenase-2 Inhibitors&#x02013;In Vitro and In Silico Studies</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0811-5235</contrib-id><name><surname>Krzy&#x0017c;anowska-Kowalczyk</surname><given-names>Justyna</given-names></name><xref ref-type="aff" rid="af1-molecules-26-00631">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7454-4762</contrib-id><name><surname>Kowalczyk</surname><given-names>Mariusz</given-names></name><xref ref-type="aff" rid="af1-molecules-26-00631">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0839-8004</contrib-id><name><surname>Ponczek</surname><given-names>Micha&#x00142; B.</given-names></name><xref ref-type="aff" rid="af2-molecules-26-00631">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7407-6716</contrib-id><name><surname>Pecio</surname><given-names>&#x00141;ukasz</given-names></name><xref ref-type="aff" rid="af1-molecules-26-00631">1</xref></contrib><contrib contrib-type="author"><name><surname>Nowak</surname><given-names>Pawe&#x00142;</given-names></name><xref ref-type="aff" rid="af2-molecules-26-00631">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8849-1067</contrib-id><name><surname>Kolodziejczyk-Czepas</surname><given-names>Joanna</given-names></name><xref ref-type="aff" rid="af2-molecules-26-00631">2</xref><xref rid="c1-molecules-26-00631" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Saso</surname><given-names>Luciano</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Blalock</surname><given-names>William</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-26-00631"><label>1</label>Department of Biochemistry and Crop Quality, Institute of Soil Science and Plant Cultivation, State Research Institute, Czartoryskich 8, 24-100 Pu&#x00142;awy, Poland; <email>jkrzyzanowska@iung.pulawy.pl</email> (J.K.-K.); <email>mkowalczyk@iung.pulawy.pl</email> (M.K.); <email>lpecio@iung.pulawy.pl</email> (&#x00141;.P.)</aff><aff id="af2-molecules-26-00631"><label>2</label>Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland; <email>michal.ponczek@biol.uni.lodz.pl</email> (M.B.P.); <email>pawel.nowak@biol.uni.lodz.pl</email> (P.N.)</aff><author-notes><corresp id="c1-molecules-26-00631"><label>*</label>Correspondence: <email>joanna.kolodziejczyk@biol.uni.lodz.pl</email>; Tel.: +48-42-635-44-83</corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2021</year></pub-date><volume>26</volume><issue>3</issue><elocation-id>631</elocation-id><history><date date-type="received"><day>11</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The <italic>Pulmonaria</italic> species (lungwort) are edible plants and traditional remedies for different disorders of the respiratory system. Our work covers a comparative study on biological actions in human blood plasma and cyclooxygenase-2 (COX-2) -inhibitory properties of plant extracts (i.e., phenolic-rich fractions) originated from aerial parts of <italic>P. obscura</italic> Dumort. and <italic>P. officinalis</italic> L. Phytochemical profiling demonstrated the abundance of phenolic acids and their derivatives (over 80% of the isolated fractions). Danshensu conjugates with caffeic acid, i.e., rosmarinic, lithospermic, salvianolic, monardic, shimobashiric and yunnaneic acids were identified as predominant components. The examined extracts (1&#x02013;100 &#x000b5;g/mL) partly prevented harmful effects of the peroxynitrite-induced oxidative stress in blood plasma (decreased oxidative damage to blood plasma components and improved its non-enzymatic antioxidant capacity). The cellular safety of the extracts was confirmed in experimental models of blood platelets and peripheral blood mononuclear cells. COX-2 inhibitor screening evidently suggested a stronger activity of <italic>P. officinalis</italic> (IC<sub>50</sub> of 13.28 and 7.24 &#x000b5;g/mL, in reaction with synthetic chromogen and physiological substrate (arachidonic acid), respectively). In silico studies on interactions of main components of the <italic>Pulmonaria</italic> extracts with the COX-2 demonstrated the abilities of ten compounds to bind with the enzyme, including rosmarinic acid, menisdaurin, globoidnan A and salvianolic acid H.</p></abstract><kwd-group><kwd>antioxidant</kwd><kwd>anti-inflammatory</kwd><kwd>blood plasma</kwd><kwd>cyclooxygenase-2</kwd><kwd>peroxynitrite</kwd><kwd><italic>Pulmonaria</italic></kwd><kwd>menisdaurin</kwd><kwd>salvianolic acid H</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-26-00631"><title>1. Introduction</title><p>The genus <italic>Pulmonaria</italic>, belonging to the Boraginaceae family, includes semi-evergreen perennials. Both <italic>Pulmonaria officinalis</italic> L. and <italic>P. obscura</italic> Dumort. species are edible plants and valuable ingredients of herbal medicines in Europe and western Asia. In the past, flowers and leaves of <italic>Pulmonaria</italic> sp. were used as wild plant food [<xref rid="B1-molecules-26-00631" ref-type="bibr">1</xref>,<xref rid="B2-molecules-26-00631" ref-type="bibr">2</xref>], and currently, these species have come back to our cuisine as components of vegan and vegetarian foods. Their aerial parts are also commercially available as <italic>Pulmonariae Herba</italic> or ingredients of various dietary supplements, herbal mixtures and tea. In Poland, <italic>Pulmonariae Herba</italic> is registered in the National Database of Health Protection Products and approved for pharmaceutical use [<xref rid="B3-molecules-26-00631" ref-type="bibr">3</xref>]. The common name of <italic>Pulmonaria</italic>, i.e., &#x0201c;lungwort&#x0201d;, derives from its traditional medicine recommendations such as treatment of disorders related to the pulmonary system (e.g., bronchitis, cold, cough, laryngitis and sore throat). Furthermore, data from numerous ethnomedicinal studies indicate that infusions and decoctions based on these plants may be also useful in the treatment of other complaints [<xref rid="B4-molecules-26-00631" ref-type="bibr">4</xref>,<xref rid="B5-molecules-26-00631" ref-type="bibr">5</xref>,<xref rid="B6-molecules-26-00631" ref-type="bibr">6</xref>,<xref rid="B7-molecules-26-00631" ref-type="bibr">7</xref>,<xref rid="B8-molecules-26-00631" ref-type="bibr">8</xref>,<xref rid="B9-molecules-26-00631" ref-type="bibr">9</xref>]. In contemporary medicine, <italic>Pulmonariae Herba</italic> is primarily used to alleviate pulmonary disorders, as an expectorant, anti-inflammatory and mucilaginous drug. Externally, lungwort is applied to heal burns, wounds, cuts and eczema [<xref rid="B10-molecules-26-00631" ref-type="bibr">10</xref>,<xref rid="B11-molecules-26-00631" ref-type="bibr">11</xref>,<xref rid="B12-molecules-26-00631" ref-type="bibr">12</xref>].</p><p>The present work is the first study on biological properties of <italic>P. obscura</italic> and <italic>P. officinalis</italic>, covering their activities in human blood plasma under the peroxynitrite-induced oxidative stress, verification of cellular safety and preliminary evaluation of anti-inflammatory potential (based on the COX-2 inhibitory tests). Despite the presence of <italic>Pulmonaria</italic> species in ethnomedicine and their use for culinary purposes, the biological activity of the lungwort-based preparations and extracts from these plants is still poorly recognized. Moreover, there is a lack of comparative studies assessing the bioactive properties of different species from the <italic>Pulmonaria</italic> genus. Most of the available evidence derived from strictly chemical assays, mostly based only on DPPH<sup>&#x02022;</sup>(1,1-diphenyl-2-picrylhydrazyl) or ABTS<sup>&#x02022;+</sup> [2,2&#x02032;-azino-<italic>bis</italic>(3-ethylbenzothiazoline-6-sulphonic acid)] radical scavenging assays [<xref rid="B13-molecules-26-00631" ref-type="bibr">13</xref>]. Furthermore, very few studies on these plants were conducted with the use of biological experimental models such as biomolecules, blood cells, or any cell lines. For example, recent studies of Neagu et al. [<xref rid="B14-molecules-26-00631" ref-type="bibr">14</xref>] have provided data on acetylcholinesterase and tyrosinase inhibitory actions of aqueous and ethanolic extracts obtained from <italic>P. officinalis</italic>. It has been also shown that the <italic>P. officinalis</italic>-derived fraction may significantly decrease the synthesis of &#x003b1;-toxin in <italic>Staphylococcus aureus</italic>, slightly weaken the expression of staphylococcal protein A and inhibit the activity of staphylococcal sortase A [<xref rid="B15-molecules-26-00631" ref-type="bibr">15</xref>].</p><p>The activity of <italic>P. obscura</italic> and <italic>P. officialis</italic> extracts was examined in a panel of different bioassays, including in vitro and in silico analyses. To the best of our knowledge, the influence of <italic>Pulmonaria</italic> extracts on the physiology of the cardiovascular system, including antioxidant action towards peroxynitrite (ONOO<sup>&#x02212;</sup>), one of the primary physiological oxidants, and their effects on components of blood plasma have not been described yet. Since the in-vivo formation of ONOO<sup>&#x02212;</sup> is strictly related to the pathophysiology of inflammation, inhibitory effects of the extracts on a pro-inflammatory enzyme, cyclooxygenase-2 (COX-2) were also evaluated. Thus, our study was based on the following questions: <italic>Can the examined extract reduce oxidative damage to blood components</italic>? <italic>Do they have any anti-inflammatory potential</italic>? Additionally, the risk of cytotoxicity of the examined plant preparations towards blood cells (incl. blood platelets and peripheral blood mononuclear cells, PBMCs) was evaluated.</p></sec><sec sec-type="results" id="sec2-molecules-26-00631"><title>2. Results</title><sec id="sec2dot1-molecules-26-00631"><title>2.1. Phytochemical Profiling</title><p>High-resolution mass spectrometry (HR-MS) analysis revealed the presence of numerous phenolic compounds; some of these compounds have well-documented biological properties. The phytochemical profiles of the examined extracts - i.e., phenolic-rich fractions obtained from <italic>P. officinalis</italic> and <italic>P. obscura</italic> were very similar, both qualitatively and quantitatively (<xref ref-type="fig" rid="molecules-26-00631-f001">Figure 1</xref>).</p><p>The examined fractions (extracts) contained several compounds belonging to various classes of metabolites. However, in both extracts, the most-represented substances were members of the broadly defined group of phenolic acids, constituting over 81% of fractions. The estimated content of individual groups of specific metabolites was presented in <xref rid="molecules-26-00631-t001" ref-type="table">Table 1</xref>. The dominant compounds were conjugates of danshensu with caffeic acid, i.e., rosmarinic, lithospermic, salvianolic, monardic, shimobashiric and yunnaneic acids. The presence of esters of caffeic acid with quinic acid (so-called chlorogenic acids), threonic and glyceric acids was also revealed. Three isomers of <italic>p</italic>-coumaroylquinic acid, a few lignans such as globoidnans A and B, pulmonariosides A and B as well as many common flavonol glycosides such as quercetin and kaempferol derivatives (including malonylated forms) were also found. Furthermore, the examined fractions contained a significant content of menisdaurin, a nitrile glucoside as well as slight amounts of megastigmane glucoside actinidioionoside and tryptophan derivative, i.e., lycoperodine-1 [<xref rid="B16-molecules-26-00631" ref-type="bibr">16</xref>].</p><p>The results of our quantitative analyses of <italic>P. obscura</italic> and <italic>P. officinalis</italic> phenolic-rich fractions are shown in <xref rid="molecules-26-00631-t002" ref-type="table">Table 2</xref>. Menisdaurin (<bold>2</bold>), caffeic acid (<bold>8</bold>), salvianolic acid H (<bold>33</bold>), glyceric acid (<bold>11</bold>, <bold>14</bold>) and threonic acid (<bold>4, 12</bold>) derivatives were present in higher concentrations in <italic>P. officinalis</italic> extract. In contrast, in the <italic>P. obscura</italic> extract, the increased concentrations of yunnaneic acid E (<bold>22</bold>), rosmarinic acid (<bold>27</bold>), monardic acid (<bold>29</bold>), lithospermic acid A (<bold>31</bold>) and globoidnan A (<bold>37</bold>) were observed.</p></sec><sec id="sec2dot2-molecules-26-00631"><title>2.2. Antioxidant Assays</title><sec id="sec2dot2dot1-molecules-26-00631"><title>2.2.1. ONOO<sup>&#x02212;</sup>-Scavenging Ability in the Evans Blue Solution</title><p>The preliminary step of our studies involved a comparative evaluation of the ONOO<sup>&#x02212;</sup>-scavenging abilities of <italic>Pulmonaria</italic> phenolic-rich fractions in a non-biological experimental system (i.e., a solution of Evans blue dye). The assay revealed similar abilities of both of these plant-derived preparations to scavenge 1 mM ONOO<sup>&#x02212;</sup>. Their efficiencies were characterized by IC<sub>50</sub> values of 36.71 &#x000b5;g/mL and 32.66 &#x000b5;g/mL, for <italic>P. obscura</italic> and <italic>P. officinalis</italic>, respectively. Furthermore, the fractions were noticeably weaker ONOO<sup>&#x02212;</sup> scavengers, when compared to reference antioxidants such as rosmarinic acid and Trolox<sup>&#x000ae;</sup> (<xref rid="molecules-26-00631-t003" ref-type="table">Table 3</xref>).</p></sec><sec id="sec2dot2dot2-molecules-26-00631"><title>2.2.2. Antioxidant Activity in Human Blood Plasma</title><p>In the next part of the study, in-vitro experiments employing human blood plasma exposed to 100 or 150 &#x003bc;M ONOO<sup>&#x02212;</sup> providing more promising results and demonstrated that the examined <italic>Pulmonaria</italic> phenolic-rich-fractions might display antioxidant effects in biological experimental systems. The investigated <italic>Pulmonaria</italic> fractions partly prevented the ONOO<sup>&#x02212;</sup>-induced decrease of the non-enzymatic antioxidant capacity of human blood plasma (NEAC; <xref ref-type="fig" rid="molecules-26-00631-f002">Figure 2</xref>). A slight effect on NEAC was observed for all the tested concentrations of <italic>Pulmonaria</italic> extracts; however, its statistical significance was found for their concentrations of 25&#x02013;100 &#x000b5;g/mL. Furthermore, at concentrations of 50&#x02013;100 &#x000b5;g/mL, the phenolic-rich fractions significantly enhanced the NEAC of blood plasma, compared to control samples (<xref ref-type="fig" rid="molecules-26-00631-f002">Figure 2</xref>). However, no statistical significance between the efficiency of <italic>P. obscura</italic> and <italic>P. officinalis</italic> extracts was found (<italic>p</italic> &#x0003e; 0.05).</p><p>Antioxidant efficacies of the examined plant preparations were also confirmed by determination of the levels of protein and lipid biomarkers of oxidative stress, i.e., 3-nitrotyrosine (3-NT), lipid hydroperoxides and the thiobarbituric acid-reactive substances (TBARS) in blood plasma. The obtained results indicated that both of the examined <italic>Pulmonaria</italic> extracts were more potent inhibitors of plasma lipid peroxidation than protein nitration. Some anti-nitrative tendency was observed for most of the tested concentrations (at 1&#x02013;100 &#x000b5;g/mL); however, a statistically significant reduction of 3-nitrotyrosine level blood plasma proteins and isolated fibrinogen was mostly found only for higher concentrations of the extracts (i.e., 25&#x02013;100 &#x000b5;g/mL) (<xref rid="molecules-26-00631-t004" ref-type="table">Table 4</xref>).</p><p>The ONOO<sup>&#x02212;</sup>-induced peroxidation of plasma lipids was significantly diminished in the presence of <italic>Pulmonaria</italic> fractions, even at their lowest concentrations (i.e., at concentrations &#x02264; 5 &#x000b5;g/mL) (<xref rid="molecules-26-00631-t005" ref-type="table">Table 5</xref>).</p></sec></sec><sec id="sec2dot3-molecules-26-00631"><title>2.3. COX-2 Inhibitor Screening Tests</title><p>In order to preliminary assess whether the examined <italic>Pulmonaria</italic> phenolic-rich fractions display any anti-inflammatory potential, a key inflammatory enzyme, i.e., COX-2 was used. In ELISA, the COX-2-dependent metabolism of arachidonic acid was evidently reduced by the <italic>P. officinalis</italic> fraction; the <italic>P. obscura</italic> extract had a weaker inhibitory action on this enzyme (<xref rid="molecules-26-00631-t006" ref-type="table">Table 6</xref>). While the IC<sub>50</sub> for <italic>P. officinalis</italic> extract was 7.24 &#x003bc;g/mL, the IC<sub>50</sub> for <italic>P. obscura</italic> fraction attained 51 &#x003bc;g/mL in this test. The colorimetric assay confirmed a higher COX-2-inhibitory potency of the fraction originated from <italic>P. officinalis</italic>, when compared to the <italic>P. obscura</italic> extract. For indomethacin (a reference COX inhibitor and anti-inflammatory drug), the IC<sub>50</sub> values were estimated to be 0.05 and 2.06 &#x003bc;g/mL, for the ELISA and colorimetric assay, respectively (<xref rid="molecules-26-00631-t006" ref-type="table">Table 6</xref>).</p></sec><sec id="sec2dot4-molecules-26-00631"><title>2.4. Assessments of Cellular Safety</title><p>The possibility of toxic action of the examined extracts towards blood cells was evaluated using three different experimental systems. The risk of direct damage to cell membranes was excluded using propidium iodide assay. No cytotoxicity towards PBMCs was found in this assay for both of the examined <italic>Pulmonaria</italic> preparations. Furthermore, the resazurin-based viability test excluded the inhibitory influence of <italic>Pulmonaria</italic> fractions on the metabolic activity of PBMCs. Cellular safety of the extracts was also confirmed in experiments on blood platelets. Due to susceptibility to damaging factors and very high reactivity in a response to different stimuli, blood platelets are very good indicators in various cytotoxicity tests. Thus, the platelet LDH-leakage assays provided additional evidence of the cellular safety of <italic>Pulmonaria</italic> extracts in vitro (<xref rid="molecules-26-00631-t007" ref-type="table">Table 7</xref>).</p></sec><sec id="sec2dot5-molecules-26-00631"><title>2.5. Prediction of Protease Inhibitors, Molecular Docking and Drug-Likeness</title><p>Based on their dominant contents (&#x02265;4 &#x000b5;g/mg of the fraction), fourteen main components of the examined <italic>Pulmonaria</italic> extracts were selected for in silico analyses. The use of predictive bioinformatics tools allowed us to analyze the possibility of interaction of the individual compounds with the COX-2 enzyme, based on mathematical analyses and energy calculations. Predict Bioactivity Cheminformatics Tool and the Vina dockings showed that ten compounds could be probable inhibitors of COX-2 in <italic>Pulmonaria</italic> plants (i.e., 2-<italic>O</italic>-<italic>E</italic>-caffeoyl-<sc>l</sc>-threonic acid (<bold>4</bold>), chlorogenic acid (<bold>6</bold>), globoidnan A (<bold>37</bold>), globoidnan B (<bold>18</bold>), lithospermic acid A (<bold>31</bold>), menisdaurin (<bold>2</bold>), monardic acid (<bold>29</bold>) rosmarinic acid (<bold>27</bold>), quercetin 3-<italic>O</italic>-(6&#x02019;&#x02019;-<italic>O</italic>-malonyl)-&#x003b2;-glucoside (<bold>23</bold>) and salvianolic acid H (<bold>33</bold>)) (<xref rid="molecules-26-00631-t008" ref-type="table">Table 8</xref>).</p><p>However, only two of them were definitely more abundant in the <italic>P. officinalis</italic> fractions (<xref rid="molecules-26-00631-t002" ref-type="table">Table 2</xref>), where the inhibition of COX&#x02013;2 activity was much stronger compared to the fraction obtained from <italic>P. obscura</italic> (<xref rid="molecules-26-00631-t006" ref-type="table">Table 6</xref>). These two compounds were menisdaurin (<bold>2</bold>) and salvianolic acid H (<bold>33</bold>), and their free energy change of binding (&#x00394;G<bold>&#x000b0;<sub>bind</sub></bold>) was much lower than values counted for indomethacin indicating on their stronger affinity when compared to this reference inhibitor. Both compounds were bound in a similar location as indomethacin in COX&#x02013;2 active site between amino acid residues Tyr 355, Tyr 385 and Ser 530, according to human protein structure numbering (<xref ref-type="fig" rid="molecules-26-00631-f003">Figure 3</xref>).</p></sec></sec><sec sec-type="discussion" id="sec3-molecules-26-00631"><title>3. Discussion</title><p>Natural, plant&#x02013;derived substances with antioxidant activity are helpful and promising agents in the prevention of different civilization disorders. On the other hand, the newest findings have indicated that the antioxidant&#x02013;based action solely may be insufficient in the prophylaxis of these diseases [<xref rid="B17-molecules-26-00631" ref-type="bibr">17</xref>,<xref rid="B18-molecules-26-00631" ref-type="bibr">18</xref>,<xref rid="B19-molecules-26-00631" ref-type="bibr">19</xref>]. Due to multifactorial pathomechanisms of Western diseases, there is a need to find substances with a broader spectrum of beneficial activities, including both antioxidant and anti-inflammatory effects. The contribution of inflammation and oxidative stress to the pathogenesis and progression of a wide range of diseases, including cardiovascular disorders, has been well documented and described in numerous papers [<xref rid="B20-molecules-26-00631" ref-type="bibr">20</xref>,<xref rid="B21-molecules-26-00631" ref-type="bibr">21</xref>,<xref rid="B22-molecules-26-00631" ref-type="bibr">22</xref>,<xref rid="B23-molecules-26-00631" ref-type="bibr">23</xref>]. The co&#x02013;existence of inflammation and oxidative stress in the cardiovascular system results in damage to the vessel wall, blood cells and non-cellular blood components, leading to undesirable changes in their biological activities. The NADPH oxidase subunits p47phox, Nox1, Nox2 and Nox4, mitochondrial ROS as well as enzymatic activities of xanthine oxidase and uncoupled eNOS are the primary sources of oxidants generated within the cardiovascular system [<xref rid="B24-molecules-26-00631" ref-type="bibr">24</xref>].</p><p>Among a variety of the reactive oxygen species that are generated within the cardiovascular system, the formation of ONOO<sup>&#x02212;</sup> is particularly important in the pathophysiology of stroke, myocardial infarction, chronic heart failure, diabetes, circulatory shock, chronic inflammatory diseases, cancer as well as neurodegenerative disorders development [<xref rid="B25-molecules-26-00631" ref-type="bibr">25</xref>]. Peroxynitrite can modify both proteins and lipids. It has been established that this potent oxidative and nitrative agent may augment [<xref rid="B26-molecules-26-00631" ref-type="bibr">26</xref>,<xref rid="B27-molecules-26-00631" ref-type="bibr">27</xref>] or diminish [<xref rid="B28-molecules-26-00631" ref-type="bibr">28</xref>] coagulant activity of fibrinogen; its pro-thrombotic effects may be also a result of modifications of fibrinolytic proteins [<xref rid="B29-molecules-26-00631" ref-type="bibr">29</xref>,<xref rid="B30-molecules-26-00631" ref-type="bibr">30</xref>].</p><p>The present work is the first study devoted to a comparative evaluation of antioxidant activity, the COX&#x02013;2 inhibitory potential and cellular safety of extracts obtained from <italic>Pulmonaria obscura</italic> and <italic>P. officinalis</italic>. The preliminary part of this work, i.e., the ONOO<sup>&#x02212;</sup> scavenging assay was based on the Evans blue decolorization and suggested moderate antioxidant effects of the <italic>Pulmonaria</italic> phenolic&#x02013;rich fractions (IC<sub>50</sub> = 36.71 and 32.66 &#x000b5;g/mL), compared to well&#x02013;known antioxidants, i.e., rosmarinic acid (IC<sub>50</sub> = 13.34 &#x000b5;g/mL) or Trolox (IC<sub>50</sub> 2.76 &#x000b5;g/mL). According to the literature, the antioxidant activity of plant extracts or individual plant&#x02013;derived compounds in this test may differ drastically. In our earlier studies, the yunnaneic acid B isolated from <italic>P. officinalis</italic> scavenged ONOO<sup>&#x02212;</sup> with the IC<sub>50</sub> = 50.45 &#x003bc;g/mL [<xref rid="B31-molecules-26-00631" ref-type="bibr">31</xref>]. The efficiency of both <italic>Pulmonaria</italic> extracts was significantly higher compared to some other plant extract, e.g., the <italic>Newbouldia laevis</italic> leaf extract, which was able to scavenge ONOO<sup>&#x02212;</sup> with IC<sub>50</sub> = 1210.83 &#x000b5;g/mL [<xref rid="B32-molecules-26-00631" ref-type="bibr">32</xref>]. On the other hand, in studies on <italic>Diplazium esculentum</italic> extract, the IC<sub>50</sub> value for this plant was 3.35 &#x000b5;g/mL, whereas the IC<sub>50</sub> for gallic acid amounted to 0.87 &#x000b5;g/mL [<xref rid="B33-molecules-26-00631" ref-type="bibr">33</xref>]. However, this common screening assay required the use of a 1 mM concentration of ONOO<sup>&#x02212;</sup>, which is unachievable in vivo. Therefore, in further steps of the study (experiments on isolated fibrinogen and blood plasma), ONOO<sup>&#x02212;</sup> was used at significantly lower concentrations (of 100 or 150 &#x000b5;M). Due to instability of peroxynitrite at physiological pH, the use of 100&#x02013;150 &#x000b5;M concentration reflects physiologically relevant levels of this oxidant, that may be formed in vivo, e.g., at sites of inflammation. According to literature, a bolus addition of 250 &#x000b5;M ONOO<sup>&#x02212;</sup> corresponds to a steady&#x02013;state level of its 1 &#x000b5;M concentrations, maintained for 7 min [<xref rid="B34-molecules-26-00631" ref-type="bibr">34</xref>].</p><p>Biological activities of the examined plant extracts were analyzed in vitro, employing a model experimental system of blood plasma or isolated protein. Our results obtained from experiments in blood plasma mostly revealed comparable antioxidant efficiencies of both of the examined <italic>Pulmonaria</italic> preparations. The extracts slightly reduced the impairment of the NEAC of blood plasma caused by ONOO<sup>&#x02212;</sup> and decreased the ONOO<sup>&#x02212;</sup>&#x02013;induced formation of 3&#x02013;nitrotyrosine in blood plasma proteins. The lipoperoxidation assays provided demonstrated significant protective effects of the examined <italic>Pulmonaria</italic> phenolic&#x02013;rich fractions at most of the tested concentrations. However, the above lipid peroxidation assays have some important limitations in the context of their use in this type of study. Both of them are only partly specific to lipoperoxidation products. In our studies, a reduction of plasma lipid peroxidation was detectable only into a level higher than 50%, in a full range of the tested concentrations of the <italic>Pulmonaria</italic> extracts (1&#x02013;100 &#x000b5;g/mL), with no dose&#x02013;dependent activity of the extracts in most cases. Additionally, at the concentrations of the extracts of 50&#x02013;100 &#x000b5;g/mL, a plateau phase of the reaction was observed, probably as a result of non-specific interactions (interference) of the extract components with reagents and other components of the assayed blood plasma samples.</p><p>Our phytochemical analyses and antioxidant assays suggested that the <italic>Pulmonaria</italic> extracts may be sources of natural antioxidants. The examined extracts contained over 80% phenolic acids and about 5% flavonols. In a context of biological activity (including antioxidant properties) of <italic>Pulmonaria</italic> extracts, the presence of considerable amounts of rosmarinic acid and its derivatives may be particularly important. With a content of 301.46 and 159.28 &#x000b5;g/mg, this compound was the predominant component of <italic>P. obscura</italic> and <italic>P. officinalis</italic> fractions, respectively. Its ability to scavenge reactive oxygen species or to prevent their generation has been confirmed by different research groups [<xref rid="B35-molecules-26-00631" ref-type="bibr">35</xref>]. Rosmarinic acid has been described as an effective reducer of peroxynitrite&#x02013;mediated damage, both at the level of peroxynitrite scavenging and inhibition of superoxide and nitric oxide synthesis [<xref rid="B36-molecules-26-00631" ref-type="bibr">36</xref>]. Furthermore, our earlier studies [<xref rid="B31-molecules-26-00631" ref-type="bibr">31</xref>], demonstrated significant protective activity of its derivative, i.e., yunnaneic acid B (also isolated from <italic>P. officinalis</italic>) against oxidative and nitrative damage induced by peroxynitrite. It is very likely that the presence of the oligomeric derivatives of rosmarinic acid such as yunnaneic acids B and E, in the examined <italic>Pulmonaria</italic> extracts also might contribute to their antioxidant effects.</p><p>Although in ethnomedicine <italic>Pulmonaria</italic> plants are used to alleviate inflammation, neither detailed information on their anti-inflammatory efficiency nor comparative assessments of biological activities of different species exist. As a key pro-inflammatory enzyme and target of many non-steroidal anti-inflammatory drugs, the COX&#x02013;2 enzyme was used in our tests. Contrary to results indicating similar antioxidant activities of both extracts, our COX&#x02013;2 inhibitor analyses revealed noticeable divergences in their effects. In the case of both the detection of the arachidonic acid metabolite (PGF2&#x003b1;) and reaction with a synthetic substrate, inhibitory actions of the extracts on COX&#x02013;2 activity clearly indicated a stronger effect of the <italic>P. officinalis</italic> extract (IC<sub>50</sub> of 7.24 and 13.28 &#x000b5;g/mL, respectively). The COX&#x02013;2 inhibitory action of <italic>P. obscura</italic> extract was lower; its IC<sub>50</sub> amounted to 51.00 and 58.59 &#x000b5;g/mL in the ELISA and colorimetric test, respectively. According to the available literature, plant extracts may inhibit this enzyme with a wide range of efficiency. For example, in studies of Ondua et al. [<xref rid="B37-molecules-26-00631" ref-type="bibr">37</xref>], the IC<sub>50</sub> for <italic>Plantago lanceolata</italic> leaf extracts was 0.41 &#x003bc;g/mL. In other work, a leaf extract prepared from <italic>Eucomis autumnalis</italic> ssp. <italic>autumnalis</italic> reduced the COX&#x02013;2 activity with the IC<sub>50</sub> of 29.00 &#x003bc;g/mL [<xref rid="B38-molecules-26-00631" ref-type="bibr">38</xref>]. Moreover, the activity of fractions originated from the same plant material also may be divergent, e.g., for two ethanolic fractions isolated from <italic>Stachys officinalis</italic> extract undergoing the micro- or nanofiltration, the IC<sub>50</sub> values amounted to 38.8 and 1.2 &#x003bc;g/mL, respectively. The IC<sub>50</sub> for quercetin (a reference compound) was 35.2 &#x003bc;g/mL [<xref rid="B39-molecules-26-00631" ref-type="bibr">39</xref>].</p><p>Our invitro screening of the COX&#x02013;2 inhibitory activity was additionally supported by in silico studies on possible interactions of main components of the extracts and the enzyme. Biochemical mechanisms of anti-inflammatory action of these plants are still inadequately recognized. However, based on current knowledge of the anti-inflammatory effects of hydroxycinnamates such as rosmarinic and chlorogenic acids, it may be predicted that their presence considerably contributed to the COX&#x02013;2 inhibitory properties of the examined plant extracts. The anti-inflammatory action of rosmarinic acid, involving different pathways of pro-inflammatory response (such as inhibition of NF&#x003ba;B activation, suppression of the complement cascade and reduction of pro-inflammatory cytokines as well as the inhibitory effect on COX&#x02013;2) was observed in vitro and in vivo [<xref rid="B40-molecules-26-00631" ref-type="bibr">40</xref>]. Similarly, chlorogenic acid also displays an anti-inflammatory effect [<xref rid="B41-molecules-26-00631" ref-type="bibr">41</xref>]. Besides the aforementioned phenolic acids, the anti-inflammatory action or COX&#x02013;inhibitory properties of other main constituents of the examined extracts has been described to a significantly lower extent. However, also other phytochemicals may be responsible for stronger inhibition of the COX&#x02013;2 by the <italic>P. officinalis</italic> extract. Although no information on the anti-inflammatory properties of globoidnan A and B is available, monardic acid A was found to inhibit hyaluronidase activity and moderately reduce histamine release in vitro [<xref rid="B42-molecules-26-00631" ref-type="bibr">42</xref>]. The anti-inflammatory activity of shimobashiric acid B has been recently described [<xref rid="B43-molecules-26-00631" ref-type="bibr">43</xref>], but there is no such evidence for its C isomer, present in the examined fractions from <italic>Pulmonaria</italic> species. The COX&#x02013;2 inhibitory activity of menisdaurin was demonstrated in a study by Muhammad and Sirat [<xref rid="B44-molecules-26-00631" ref-type="bibr">44</xref>]. In analyses of COX&#x02013;2 inhibitors, isolated from the stem bark of <italic>Bauhinia rufescens</italic>, menisdaurin inhibited the enzyme with the IC<sub>50</sub> value of 72.28 &#x003bc;M (22.6 &#x003bc;g/mL), whereas the IC<sub>50</sub> for the positive control, indomethacin was of 0.24 &#x003bc;M (0.085 &#x003bc;g/mL). Our in vitro and in silico observations are in agreement with the cited results and indicate that menisdaurin (39.08 &#x000b1; 1.56 &#x000b5;g/mg of the fraction, <xref rid="molecules-26-00631-t002" ref-type="table">Table 2</xref>), which is more abundant in <italic>P. officinalis</italic>, may be a potent inhibitor of COX&#x02013;2. However, it should be emphasized that this compound was detected only in <italic>Pulmonaria</italic> samples collected during the spring, whereas samples collected in the autumn did not contain menisdaurin at all [<xref rid="B16-molecules-26-00631" ref-type="bibr">16</xref>]. The other significant inhibitor of COX&#x02013;2 in <italic>P. officinalis</italic> phenolic&#x02013;rich fraction may be salvianolic acid H (26.23 &#x000b1; 0.75 &#x000b5;g/mg of the extract) as we also showed its strong affinity to COX&#x02013;2 active site in molecular docking (<xref rid="molecules-26-00631-t008" ref-type="table">Table 8</xref>, <xref ref-type="fig" rid="molecules-26-00631-f003">Figure 3</xref>A). According to the UniProt P35354 record, the Tyr 324, Tyr 353 and Ser 499 residues are important for COX&#x02013;2 enzymatic function (<xref ref-type="fig" rid="molecules-26-00631-f003">Figure 3</xref>). Tyr 321 is substrate binding site, Tyr 353 is the cyclooxygenase active site, and Ser 499 is the aspirin&#x02013;acetylated site. Indomethacin and other non-steroidal anti-inflammatory drugs bind there as COX&#x02013;2 inhibitors (<xref ref-type="fig" rid="molecules-26-00631-f003">Figure 3</xref>C). Salvianolic acid H and menisdaurin are bound there according to our molecular docking studies, which can confirm that they are important COX&#x02013;2 inhibitor compounds in <italic>P. officinalis</italic>, responsible to a large extent for the observed effect of a stronger inhibition of COX&#x02013;2 enzyme activity by extract isolated from this plant species.</p><p>The presented work provides some evidence of the bioactivity of extracts from <italic>P. obscura</italic> and <italic>P. officinalis</italic>. The obtained results suggested that both plants are a source of phytochemicals with antioxidant and cyclooxygenase-inhibitory activity in vitro; however, the observed activity may not be maintained in vivo. The evaluation of the physiological relevance of these effects requires further, more advanced tests, including in vivo studies and experiments on the digested/hydrolyzed plant material. Biological activity (including the mechanisms of antioxidant action) of the digested extracts may differ from the reactive oxygen species scavenging properties of the non-hydrolyzed substances. Contemporary use of plant&#x02013;derived substances includes their external and internal applications. Herbal ointments, balms and gels are used in the treatment of dermatological disorders, e.g., to alleviate inflammation and to heal skin irritations and wounds of different etiology. In the case of external applications of plant material, indigested extracts might be active, but in the case of internal use, many additional aspects of their activity should be established. For that reason, further studies on the <italic>Pulmonaria</italic>&#x02013;derived extracts, covering analyses of the digested extracts and in vivo assays are needed.</p></sec><sec id="sec4-molecules-26-00631"><title>4. Materials and Methods</title><sec id="sec4dot1-molecules-26-00631"><title>4.1. Reagents</title><p>Chloroform, methanol (isocratic grade) and acetonitrile (LC&#x02013;MS grade) were purchased from Merck (Darmstadt, Germany). Formic acid (LC&#x02013;MS grade) and digoxin (internal standard, IS) were purchased from Sigma&#x02013;Aldrich (St. Louis, MO, USA). Ultrapure water was prepared using a Milli&#x02013;Q water purification system (Millipore, Milford, CT, USA). Peroxynitrite was synthesized according to the method of Pryor et al. [<xref rid="B40-molecules-26-00631" ref-type="bibr">40</xref>]. DPPH, Trolox<sup>&#x000ae;</sup>, rosmarinic acid, thiobarbituric acid, Histopaque<sup>&#x000ae;</sup>&#x02013;1077 medium, indomethacin, penicillin&#x02013;streptomycin solution for cell culture and resazurin (In vitro toxicology assay kit, Resazurin based, TOX8&#x02013;1KT) were also purchased from Sigma&#x02013;Aldrich (St. Louis, MO, USA). COX (human) Inhibitor Screening Assay Kit (Item No. 701230) and COX Colorimetric Inhibitor Screening Assay Kit (Item No. 701050) were from Cayman Chemicals (Ann Arbor, MI, USA). Reagents and cuvettes for cytotoxicity assays were purchased from NanoEnTek Inc. (Seoul, Korea). All other reagents were provided by local or international suppliers (mainly Avantor Performance Materials, Gliwice, Poland).</p></sec><sec id="sec4dot2-molecules-26-00631"><title>4.2. Plant Material</title><p>Aerial parts (early spring flowering shoots) of <italic>P. obscura</italic> Dumort. were collected from natural habitat in Pu&#x00142;awy (N51&#x000b0;24&#x02032;42.4&#x0201d; E21&#x000b0;57&#x02032;30&#x0201d;), whereas aerial parts of <italic>P. officinalis</italic> L. were gathered from the national herb producer (Kania, Cz&#x00119;stochowa, Poland). The voucher samples of both species (POBSC./EXTR/NH/2013/1) and (POFF./EXTR/2013/1) respectively have been deposited at the Department of Biochemistry and Crop Quality, Institute of Soil Science and Plant Cultivation, Pu&#x00142;awy, Poland.</p></sec><sec id="sec4dot3-molecules-26-00631"><title>4.3. Preparation and Quantitative Analysis of P. obscura and P. officinalis Phenolic&#x02013;Rich Fractions</title><p>Preparation and quantitative analysis of the examined plant extracts, i.e., <italic>P. obscura</italic> and <italic>P. officinalis</italic> phenolic&#x02013;rich fractions were executed according to our previously developed procedures [<xref rid="B16-molecules-26-00631" ref-type="bibr">16</xref>]. Defatted plant material was extracted twice with 80% aq. methanol (<italic>v</italic>/<italic>v</italic>), at room temperature for 24 h, using the ultrasonic bath. The obtained extracts were filtered, concentrated under reduced pressure and lyophilized. Crude extracts of <italic>P. obscura</italic> and <italic>P. officinalis</italic> were fractionated using solid phase extraction on RP&#x02013;C18 column (80 &#x000d7; 100 mm, Cosmosil 140C18&#x02013;PREP, 140 &#x000b5;m; NacalaiTesque, INC., Kyoto, Japan). Each of the extracts was firstly dissolved in 1% MeOH (<italic>v</italic>/<italic>v</italic>) and independently loaded on the preconditioned RP&#x02013;C18 column. 1% MeOH was also applied to remove polar constituents, while a phenolics&#x02013;rich fraction was eluted using 50% MeOH (<italic>v</italic>/<italic>v</italic>). Methanol was then removed under reduced pressure, and the residual material was freeze&#x02013;dried (Gamma 2&#x02013;16 LSC, Christ, Osterode am Harz, Germany) and used for biological activity tests.</p><p>Determination of specialized metabolites in obtained fractions of both <italic>Pulmonaria</italic> species was carried out as described previously [<xref rid="B16-molecules-26-00631" ref-type="bibr">16</xref>], using the Thermo Scientific Ultimate 3000 RS (Thermo Fischer Scientific, Waltham, MA, USA) liquid chromatography (LC) system, coupled with a Bruker Impact II HD (Bruker, Billerica, MA, USA) electrospray ionization high&#x02013;resolution quadrupole&#x02013;time&#x02013;of&#x02013;flight mass spectrometer (ESI&#x02013;HR Q&#x02013;TOF&#x02013;MS) and the same analytical procedure.</p><p>For analyses of biological activity, stock solutions of the examined <italic>Pulmonaria</italic> phenolic&#x02013;rich fractions and rosmarinic acid (a reference compound) were prepared using 25% DMSO; the stock solution of Trolox was dissolved in 50% ethanol. The final concentration of these solvents in experimental systems, including the Evans Blue solution, blood plasma, platelet&#x02013;rich plasma (PRP), or PBMCs suspensions amounted to 0.025% and 0.05%, respectively.</p></sec><sec id="sec4dot4-molecules-26-00631"><title>4.4. Peroxynitrite (ONOO<sup>&#x02212;</sup>) Scavenging Assay</title><p>The assay was carried out according to our previously described protocol [<xref rid="B45-molecules-26-00631" ref-type="bibr">45</xref>]. Briefly, the method was based on the prevention of peroxynitrite&#x02013;mediated oxidation of Evans blue dye by the examined substances. Their ONOO<sup>&#x02212;</sup>&#x02013;scavenging abilities were determined indirectly, i.e., by measurements of the inhibition of Evans blue bleaching (at &#x003bb; = 608 nm). A decrease of the Evans dye color, induced by 1 mM ONOO<sup>&#x02212;</sup>, was calculated using the following equation: % of sample bleaching = 100 &#x000d7; (A0&#x02013;A1)/A0. The absorbance of control samples (untreated with ONOO<sup>&#x02212;</sup>) was assumed as A0 value, while A1 was the absorbance recorded after 30 min of incubation of reaction mixtures (containing 1 mM ONOO<sup>&#x02212;</sup> and the investigated <italic>Pulmonaria</italic> extracts (1&#x02013;100 &#x000b5;g/mL), or reference substances (1&#x02013;50 &#x000b5;g/mL)). Results obtained for samples treated with ONOO<sup>&#x02212;</sup>&#x02013; in the absence of the antioxidants were then assumed as 100% of Evans Blue dye oxidation (bleaching).</p></sec><sec id="sec4dot5-molecules-26-00631"><title>4.5. Preparation of Blood Plasma Samples</title><p>Human blood was purchased from the Regional Centre of Blood Donation and Blood Treatment in Lodz, Poland. All blood units were commercially available. The study was approved by the committee on the Ethics of Research at the University of Lodz, Poland (Protocol No. 9/KBBN&#x02013;U&#x00141;/II/2016).</p><p>In the antioxidant part of the study, rosmarinic acid and Trolox were used as positive controls. Blood plasma samples were pre&#x02013;incubated for 15 min, at room temperature, with the <italic>Pulmonaria</italic> fractions (1&#x02013;100 &#x000b5;g/mL) or reference antioxidants. For the evaluation of antioxidant actions of all these substances in blood plasma, the samples were exposed to ONOO<sup>&#x02212;</sup>, which was added to the final concentrations of 100 &#x000b5;M (in the 3&#x02013;nitrotyrosine (3&#x02013;NT), thiobarbituric acid&#x02013;reactive substances (TBARS) and lipid hydroperoxide assays) or 150 &#x000b5;M (in the non-enzymatic antioxidant capacity assay, NEAC). Samples containing plasma treated with ONOO<sup>&#x02212;</sup> in the absence of the <italic>Pulmonaria</italic> fractions were also prepared. Control plasma was treated with neither the investigated extracts/reference antioxidants nor ONOO<sup>&#x02212;</sup>; however, it contained 0.025% DMSO (a vehicle for the extracts).</p></sec><sec id="sec4dot6-molecules-26-00631"><title>4.6. Determination of Antioxidant Capacity of Blood Plasma Using DPPH<sup>&#x02022;</sup> Assay</title><p>The assay was based on the evaluation of the non-enzymatic antioxidant capacity (NEAC) of blood plasma under the 150 &#x000b5;M ONOO<sup>&#x02212;</sup>&#x02013;induced oxidative stress [<xref rid="B46-molecules-26-00631" ref-type="bibr">46</xref>,<xref rid="B47-molecules-26-00631" ref-type="bibr">47</xref>]. For the assay, 20 &#x000b5;L of blood plasma was diluted using 380 &#x000b5;L of 0.05 M phosphate&#x02013;buffered saline (PBS, pH 7.4) The stock solution of DPPH<sup>&#x02022;</sup> (500 &#x000b5;M) in methanol was diluted in this alcohol for obtaining a working reagent, with initial absorbance of 1.2 (at 517 nm). Then, 400 &#x003bc;L of the diluted blood plasma was mixed with 400 &#x000b5;L of the working solution of DPPH<sup>&#x02022;</sup>. Reagent mixtures were incubated for 30 min, at room temperature. After centrifugation, the absorbance of clear supernatants was measured and compared with the background sample (containing 400 &#x000b5;L of PBS + 400 &#x000b5;L of DPPH<sup>&#x02022;</sup> working solution). The antioxidant capacity of blood plasma was calculated using the following equation: the DPPH<sup>&#x02022;</sup> scavenging ability = (A0&#x02013;A1)/A0. The initial absorbance of DPPH<sup>&#x02022;</sup> solution was assumed as A0, and the A1 was absorbance obtained for the examined samples. The DPPH<sup>&#x02022;</sup> scavenging ability of control (untreated) plasma was assumed as 100% of NEAC.</p></sec><sec id="sec4dot7-molecules-26-00631"><title>4.7. Determination of Lipid Peroxidation Biomarkers in Blood Plasma Exposed to 100 &#x000b5;M ONOO<sup>&#x02212;</sup></title><p>The determination of hydroperoxide level in blood plasma was performed using the FOX&#x02013;1 (ferric&#x02013;xylenol orange) protocol [<xref rid="B48-molecules-26-00631" ref-type="bibr">48</xref>], while the TBARS were assayed according to the method described by Wachowicz [<xref rid="B49-molecules-26-00631" ref-type="bibr">49</xref>]. Rosmarinic acid and Trolox<sup>&#x000ae;</sup> (5 &#x000b5;g/mL) were used as reference antioxidants.</p></sec><sec id="sec4dot8-molecules-26-00631"><title>4.8. Immunodetection of 3&#x02013;NT in Blood Plasma and Experimental System of the Isolated Fibrinogen Preparation</title><p>3&#x02013;NT was used as a biomarker of the 100 &#x000b5;M ONOO<sup>&#x02212;</sup>&#x02013;induced damage to blood plasma proteins. Experiments were conducted using two biological models, i.e., blood plasma and the isolated human fibrinogen (2 mg/mL, in 0.01 M Tris/HCl buffer, pH 7.4). The pre&#x02013;incubation of blood plasma or fibrinogen (15 min, at room temperature) with the examined <italic>Pulmonaria</italic> extracts (i.e., 50% methanolic fractions; 1&#x02013;100 &#x000b5;g/mL) or reference oxidants was followed by exposure to peroxynitrite (100 &#x000b5;M). The immunodetection of 3&#x02013;NT was performed using a competitive enzyme&#x02013;linked immunosorbent assay (ELISA), as described previously [<xref rid="B50-molecules-26-00631" ref-type="bibr">50</xref>].</p></sec><sec id="sec4dot9-molecules-26-00631"><title>4.9. Evaluation of COX&#x02013;2 Inhibitory Effects</title><p>Chemical reactions of the applied ELISA involved the COX&#x02013;catalyzed metabolism of arachidonic acid, yielding PGF<sub>2</sub>&#x003b1;, a product of the reduction of prostaglandin H<sub>2</sub> (PGH<sub>2</sub>). In addition to ELISA, abilities of the <italic>Pulmonaria</italic>&#x02013;derived phenolic&#x02013;rich fractions to inhibit COX&#x02013;2 were confirmed in a colorimetric test, measuring the enzymatic activity of peroxidase component of COX, responsible for the oxidation of the <italic>N</italic>,<italic>N</italic>,<italic>N</italic>&#x02032;,<italic>N</italic>&#x02032;&#x02013;tetramethyl&#x02013;<italic>p</italic>&#x02013;phenylenediamine (TMPD) chromogenic substrate. The positive control was indomethacin, a well&#x02013;known non-steroidal anti-inflammatory drug. Inhibitory actions of the plant extracts and a reference COX inhibitor (indomethacin) were examined at their final concentrations of 1&#x02013;100 &#x000b5;g/mL, following the manufacturer&#x02019;s protocols. Assays were carried out in triplicate or quadruplicate.</p><p>Both the COX&#x02013;2 activity and the IC<sub>50</sub> values were calculated following directions and calculation patterns provided by a manufacturer of the used reagent kits. The activity of control (untreated) sample was assumed as 100% (of the maximum of antibody binding or the enzyme activity in the ELISA test and colorimetric assay, respectively). The ELISA: the maximum&#x02013;binding well (B<sub>0</sub>) absorbance was averaged. Then, the %B/B<sub>0</sub> (% of sample or standard bound/maximum bound) ratio was calculated (i.e., ratio of the assayed sample or standard absorbance to the B<sub>0</sub> (maximum bound) well absorbance). The IC<sub>50</sub> was calculated from a standard curve, constructed as the plot %B/B<sub>0</sub> versus the concentration of the analyzed extracts or reference compound (indomethacin). In the colorimetric assay, the absorbance was averaged within each type of samples; the absorbance of the examined sample was subtracted from the absorbance of the 100% activity sample (control/untreated sample) and multiplied by 100 in order to obtain the percent inhibition. The IC<sub>50</sub> was estimated using a standard curve constructed from the percent inhibition data versus the concentration of the analyzed extracts or reference compound.</p></sec><sec id="sec4dot10-molecules-26-00631"><title>4.10. Cytotoxicity Assays</title><p>Cytotoxicity of the examined <italic>Pulmonaria</italic> fractions was evaluated using two experimental models: peripheral blood mononuclear cells and blood platelets. PBMCs were isolated from fresh human blood, according to the protocol provided by the manufacturer. In preliminary tests, a direct influence of the examined extracts on PBMCs was assessed in cells suspended only in phosphate&#x02013;buffered saline (0.02 M PBS, containing 1 &#x000d7; 10<sup>6</sup> of cells/mL) and incubated with the examined plant extracts (1&#x02013;100 &#x000b5;g/mL) for 4 h, at 37 &#x000b0;C. This direct exposure of PBMCs to the <italic>Pulmonaria</italic> preparations quickly provided data if these extracts might generate damage to cell membranes. Then, cell viability (%) was estimated spectrofluorometrically, in a microchip&#x02013;type automatic cell counter Adam&#x02013;MC DigitalBio (NanoEnTek Inc., Seoul, Korea), using propidium iodide as a fluorescent dye.</p><p>Effects of the <italic>Pulmonaria</italic> phenolic&#x02013;rich fractions on PBMCs viability were also evaluated employing the resazurin metabolism assay after 24 h of incubation. In this test, PBMCs were suspended in RPMI&#x02013;1640 medium (1.5 &#x000d7; 10<sup>6</sup> of cells/mL) and incubated in 96&#x02013;well microplates with the examined <italic>Pulmonaria</italic> fractions (1&#x02013;100 &#x000b5;g/mL) for 24 h, in 37 &#x000b0;C, at 5% of CO<sub>2</sub> concentration and 95% humidity. After the incubation, the resazurin solution was added (to the final concentration of 10%). Cell viability was recorded after 4 h of incubation with resazurin under analogous conditions, using a microplate spectrophotometer BMG Labtech SectroStarNano, at &#x003bb; = 600 nm (690 nm was a reference wavelength).</p><p>Additionally, the possibility of toxic action of the examined extracts towards blood platelets was evaluated, based on measurements of lactate dehydrogenase (LDH) activity in platelet&#x02013;poor plasma (PPP, a physiological medium of blood platelets). Since blood platelets are very susceptible to the action of different exogenous substances, these cells are used as a trustworthy indicator of cytotoxicity of different compounds, including plant extracts. The assay was carried out according to a previously described protocol [<xref rid="B51-molecules-26-00631" ref-type="bibr">51</xref>]. Briefly, platelet&#x02013;rich plasma (PRP) was preincubated for 30 min (at 37 &#x000b0;C) with the investigated fractions (1&#x02013;100 &#x000b5;g/mL). Then, PRP samples were centrifuged, and clear supernatants of PPP were collected. The LDH leakage was determined and expressed as a percentage of LDH activity recorded in control samples (obtained from PRP, untreated with the examined <italic>Pulmonaria</italic> phenolic&#x02013;rich fractions).</p></sec><sec id="sec4dot11-molecules-26-00631"><title>4.11. In Silico Study: Prediction of Bioactivity and Docking</title><p>The prediction of bioactivity and drug&#x02013;likeness properties of main components of the examined <italic>Pulmonaria</italic> phenolic&#x02013;rich fractions were performed using Molinspiration Cheminformatics website&#x02013;calculation of Molecular Properties and Bioactivity Score&#x02013;Predict Bioactivity tool (<uri xlink:href="http://www.molinspiration.com/cgi&#x02013;bin/properties">http://www.molinspiration.com/cgi&#x02013;bin/properties</uri>). Dockings of the most common compounds detected in <italic>Pulmonaria</italic> fractions to COX&#x02013;2 crystal structure were performed in Autodock Vina 1.1.2 (<uri xlink:href="http://vina.scripps.edu/">http://vina.scripps.edu/</uri>) [<xref rid="B52-molecules-26-00631" ref-type="bibr">52</xref>]. Coordinates of COX&#x02013;2 4 COX [<xref rid="B53-molecules-26-00631" ref-type="bibr">53</xref>], which contains bound indomethacin, were downloaded from RCSB Protein Data Bank (<uri xlink:href="http://www.rcsb.org/">http://www.rcsb.org/</uri>) [<xref rid="B53-molecules-26-00631" ref-type="bibr">53</xref>]. The PDB file was deprived manually of all HETATM atoms including inhibitor atoms to free its binding site. Additionally, indomethacin structure was implemented as a reference compound and was also docked to calculate its binding enthalpy and to compare with the crystal structure. 3D ligand structures were found on PubChem (<uri xlink:href="https://pubchem.ncbi.nlm.nih.gov/">https://pubchem.ncbi.nlm.nih.gov/</uri>) or ChemSpider (<uri xlink:href="http://www.chemspider.com/">http://www.chemspider.com/</uri>) websites and converted to MOL2 format using Open Babel (<uri xlink:href="http://openbabel.org">http://openbabel.org</uri>). Geometries of the ligand structures were optimized in Avogadro (<uri xlink:href="http://avogadro.cc">http://avogadro.cc</uri>) [<xref rid="B54-molecules-26-00631" ref-type="bibr">54</xref>] using the MMFF94 force field [<xref rid="B55-molecules-26-00631" ref-type="bibr">55</xref>]. The coordinates of the ligands and the protein structures were prepared properly for docking in ADT software (<uri xlink:href="http://autodock.scripps.edu/resources/adt">http://autodock.scripps.edu/resources/adt</uri>) [<xref rid="B56-molecules-26-00631" ref-type="bibr">56</xref>]. 10&#x02013;fold dockings and thereafter parsing of affinity energy for all compounds were automated by scripts written in Python. Autodock Vina docking volume of 4COX covered boxes of two similar, opposite indomethacin binding places with center coordinates x, y, z: 24.864, 24.048, 10.330 and 69.785, 20.297, 7.825, respectively. The dimensions of both cubes were established as 26, 26, 26 covering the active sites of the enzyme molecules. Visualization of the docking poses with protein was prepared in UCSF Chimera 1.10 (<uri xlink:href="http://www.cgl.ucsf.edu/chimera/">http://www.cgl.ucsf.edu/chimera/</uri>) [<xref rid="B57-molecules-26-00631" ref-type="bibr">57</xref>].</p></sec><sec id="sec4dot12-molecules-26-00631"><title>4.12. Statistical Analysis</title><p>The first step of statistical analysis included the elimination of the uncertain data by the Q&#x02013;Dixon test. The statistical significance was evaluated using the Dunnett&#x02019;s test or Student&#x02019;s (with Bonferroni correction) <italic>t</italic>-test. All assays were done at least in duplicate (at least two independent pre&#x02013;incubations of the <italic>Pulmonaria</italic> phenolic&#x02013;rich fractions with plasma, isolated fibrinogen preparations, PBMCs, or PRP from each donor were performed). Values in this study are expressed as mean &#x000b1; SD; <italic>p</italic> &#x0003c; 0.05 was assumed as statistically significant; <italic>n</italic> = number of independent experiments/blood donors.</p></sec></sec><sec sec-type="conclusions" id="sec5-molecules-26-00631"><title>5. Conclusions</title><p>The present study provides new information on antioxidant and the COX&#x02013;2&#x02013;inhibitory activities of plant phenolic&#x02013;rich fractions, derived from two <italic>Pulmonaria</italic> species. Both of the examined fractions displayed comparable antioxidant properties, but the COX&#x02013;2 inhibitor screening clearly indicated on higher inhibitory potential of <italic>P. officinalis</italic>. In addition to literature data on the anti-inflammatory activity of rosmarinic acid, the in silico part of this study demonstrated that also other components of the examined plant extracts displayed the COX&#x02013;2 &#x02013;inhibitory potential. General insight into results of in silico studies and analyses of the phytochemical profile of both extracts suggest that the <italic>Pulmonaria</italic> phytochemicals, especially salvianolic acid H and menisdaurin may contribute to the COX&#x02013;2 inhibitory effects of <italic>P. officinalis</italic>. These observations may be an interesting background for further studies on the anti-inflammatory potential of <italic>Pulmonaria</italic> plants.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank Ilona Ku&#x0015b;mierek, M.Sc., for her very helpful assistance in a part of bioassays and Barbara Ciarkowska for technical assistance.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, J.K.-K.; methodology, J.K.-K., M.K., J.K.-C. and M.B.P.; validation J.K.-K. and J.K.-C.; formal analysis, J.K.-K. and M.K.; investigation, J.K.-K. M.K., J.K.-C. and M.B.P.; resources, J.K.-K.; data curation, J.K.-K.; writing&#x02014;original draft preparation, J.K.-K. and J.K.-C.; writing&#x02014;review and editing, M.K., &#x00141;.P., M.B.P., P.N.; visualization, J.K.-K., J.K.-C. and M.B.P.; supervision, J.K.-K.; project administration, J.K.-K.; funding acquisition, J.K.-K. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research was funded by the National Science Centre, Poland, grant number UMO&#x02013;2013/11/D/NZ9/02771. The accomplishment of experiments not covered by the above project was supported by University of Lodz, Poland, grant number 506/1136.</p></notes><notes><title>Institutional Review Board Statement</title><p>Experiments were conducted using commercially available blood units. The study was approved by the committee on the Ethics of Research at the University of Lodz, Poland (Protocol No. 9/KBBN&#x02013;U&#x00141;/II/2016; 10.11.2016).</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><notes><title>Sample Availability</title><p>Samples of the extracts are available from the authors.</p></notes><ref-list><title>References</title><ref id="B1-molecules-26-00631"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x00141;uczaj</surname><given-names>&#x00141;.</given-names></name><name><surname>Szyma&#x00144;ski</surname><given-names>W.M.</given-names></name></person-group><article-title>Wild vascular plants gathered for consumption in the Polish countryside: A review</article-title><source>J. Ethnobiol. Ethnomed.</source><year>2007</year><volume>3</volume><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1186/1746-4269-3-17</pub-id><?supplied-pmid 17433114?><pub-id pub-id-type="pmid">17201916</pub-id></element-citation></ref><ref id="B2-molecules-26-00631"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x00141;uczaj</surname><given-names>&#x00141;.</given-names></name></person-group><article-title>Wild food plants used in Poland from the mid-19th century to the present</article-title><source>Etnobiol. Pol.</source><year>2011</year><volume>1</volume><fpage>57</fpage><lpage>125</lpage></element-citation></ref><ref id="B3-molecules-26-00631"><label>3.</label><element-citation publication-type="web"><article-title>National Database of Health Protection Products</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://kbpoz.gs1.pl/">http://kbpoz.gs1.pl/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-05-27">(accessed on 27 May 2019)</date-in-citation></element-citation></ref><ref id="B4-molecules-26-00631"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ti&#x00163;&#x00103;</surname><given-names>I.</given-names></name><name><surname>Mogo&#x0015f;anu</surname><given-names>G.D.</given-names></name><name><surname>Ti&#x00163;&#x00103;</surname><given-names>M.G.</given-names></name></person-group><article-title>Ethnobotanical inventory of medicinal plants from the South-West of Romania</article-title><source>Farmacia</source><year>2009</year><volume>57</volume><fpage>141</fpage><lpage>156</lpage></element-citation></ref><ref id="B5-molecules-26-00631"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Red&#x0017e;i&#x00107;</surname><given-names>S.S.</given-names></name></person-group><article-title>The ecological aspect of ethnobotany and ethnopharmacology of population in Bosnia and Herzegovina</article-title><source>Coll. Antropol.</source><year>2007</year><volume>3</volume><fpage>869</fpage><lpage>890</lpage></element-citation></ref><ref id="B6-molecules-26-00631"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markovi&#x00107;</surname><given-names>M.</given-names></name><name><surname>Ma;tovi&#x00107;</surname><given-names>M.</given-names></name><name><surname>Pa;vlovi&#x00107;</surname><given-names>D.</given-names></name><name><surname>Zla;tkovi&#x00107;</surname><given-names>B.</given-names></name><name><surname>Ma;rkovi&#x00107;</surname><given-names>A.</given-names></name><name><surname>Joti&#x00107;</surname><given-names>B.</given-names></name><name><surname>Sta;nkov-Jova;novi&#x00107;</surname><given-names>V.</given-names></name></person-group><article-title>Resources of medicinal plants and herbs collector&#x02019;s calendar of Pirot County (Serbia)</article-title><source>Biol. Nyssana</source><year>2010</year><volume>1</volume><fpage>9</fpage><lpage>21</lpage></element-citation></ref><ref id="B7-molecules-26-00631"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zlatkovi&#x00107;</surname><given-names>B.</given-names></name><name><surname>Bogosavljevi&#x00107;</surname><given-names>S.</given-names></name></person-group><article-title>Taxonomic and pharmacological valorization of the medical flora in Svrlji&#x00161;kiTimok Gorge (Eastern Serbia)</article-title><source>Facta Univ. Ser. Med. Biol.</source><year>2014</year><volume>16</volume><fpage>76</fpage><lpage>86</lpage></element-citation></ref><ref id="B8-molecules-26-00631"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kochmarov</surname><given-names>V.</given-names></name><name><surname>Kozuharova</surname><given-names>E.</given-names></name><name><surname>Naychov</surname><given-names>Z.</given-names></name><name><surname>Momekov</surname><given-names>G.</given-names></name><name><surname>Mincheva</surname><given-names>I.</given-names></name></person-group><article-title>Ethnobotany and ethnopharmacology of <italic>Arum maculatum</italic> L. (Araceae) in Bulgaria with an emphasis on its effects against hemorrhoids</article-title><source>Int. J. Pharm. Chem. Biol.</source><year>2015</year><volume>5</volume><fpage>394</fpage><lpage>402</lpage></element-citation></ref><ref id="B9-molecules-26-00631"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leporatti</surname><given-names>M.L.</given-names></name><name><surname>Ivancheva</surname><given-names>S.</given-names></name></person-group><article-title>Preliminary comparative analysis of medicinal plants used in the traditional medicine of Bulgaria and Italy</article-title><source>J. Ethnopharmacol.</source><year>2003</year><volume>87</volume><fpage>123</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(03)00047-3</pub-id><pub-id pub-id-type="pmid">12860298</pub-id></element-citation></ref><ref id="B10-molecules-26-00631"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilca</surname><given-names>M.</given-names></name><name><surname>Tiplica</surname><given-names>G.S.</given-names></name><name><surname>Salavastru</surname><given-names>C.M.</given-names></name></person-group><article-title>Traditional and ethnobotanical dermatology practices in Romania and other Eastern European countries</article-title><source>Clin. Derm.</source><year>2018</year><volume>36</volume><fpage>338</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1016/j.clindermatol.2018.03.008</pub-id></element-citation></ref><ref id="B11-molecules-26-00631"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akram</surname><given-names>M.</given-names></name><name><surname>Rashid</surname><given-names>A.</given-names></name></person-group><article-title>Anti-coagulant activity of plants: Mini review</article-title><source>J. Thromb. Thrombol.</source><year>2017</year><volume>44</volume><fpage>406</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1007/s11239-017-1546-5</pub-id></element-citation></ref><ref id="B12-molecules-26-00631"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawry&#x00142;</surname><given-names>M.A.</given-names></name><name><surname>Waksmundzka-Hajnos</surname><given-names>M.</given-names></name></person-group><article-title>Micro 2D-TLC of selected plant extracts in screening of their composition and antioxidative properties</article-title><source>Chromatographia</source><year>2013</year><volume>76</volume><fpage>1347</fpage><lpage>1352</lpage><pub-id pub-id-type="doi">10.1007/s10337-013-2490-y</pub-id><?supplied-pmid 24078742?><pub-id pub-id-type="pmid">24078742</pub-id></element-citation></ref><ref id="B13-molecules-26-00631"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanova</surname><given-names>D.</given-names></name><name><surname>Gerova</surname><given-names>D.</given-names></name><name><surname>Chervenkov</surname><given-names>T.</given-names></name><name><surname>Yankova</surname><given-names>T.</given-names></name></person-group><article-title>Polyphenols and antioxidant capacity of Bulgarian medicinal plants</article-title><source>J. Ethnopharmacol.</source><year>2005</year><volume>96</volume><fpage>145</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2004.08.033</pub-id><?supplied-pmid 15588663?><pub-id pub-id-type="pmid">15588663</pub-id></element-citation></ref><ref id="B14-molecules-26-00631"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neagu</surname><given-names>E.</given-names></name><name><surname>Radu</surname><given-names>G.L.</given-names></name><name><surname>Albu</surname><given-names>C.</given-names></name><name><surname>Paun</surname><given-names>G.</given-names></name></person-group><article-title>Antioxidant activity, acetylcholinesterase and tyrosinase inhibitory potential of <italic>Pulmonaria officinalis</italic> and <italic>Centariumumbellatum</italic> extracts</article-title><source>Saudij. Biol. Sci.</source><year>2018</year><volume>25</volume><fpage>578</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1016/j.sjbs.2016.02.016</pub-id><?supplied-pmid 29686522?><pub-id pub-id-type="pmid">29686522</pub-id></element-citation></ref><ref id="B15-molecules-26-00631"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadowska</surname><given-names>B.</given-names></name><name><surname>W&#x000f3;jcik</surname><given-names>U.</given-names></name><name><surname>Krzy&#x0017c;anowska-Kowalczyk</surname><given-names>J.</given-names></name><name><surname>Kowalczyk</surname><given-names>M.</given-names></name><name><surname>Stochmal</surname><given-names>A.</given-names></name><name><surname>Rywaniak</surname><given-names>J.</given-names></name><name><surname>Burzy&#x00144;ska</surname><given-names>J.</given-names></name><name><surname>R&#x000f3;&#x0017c;alska</surname><given-names>B.</given-names></name></person-group><article-title>The <italic>pros</italic> and <italic>cons</italic> of cystic fibrosis (CF) patient use of herbal supplements containing <italic>Pulmonaria officinalis</italic> L. extract: The evidence from an in vitro study on <italic>Staphylococcus aureus</italic> CF clinical isolates</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1151</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24061151</pub-id><?supplied-pmid 30909529?><pub-id pub-id-type="pmid">30909529</pub-id></element-citation></ref><ref id="B16-molecules-26-00631"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krzy&#x0017c;anowska-Kowalczyk</surname><given-names>J.</given-names></name><name><surname>Pecio</surname><given-names>&#x00141;.</given-names></name><name><surname>Mo&#x00142;doch</surname><given-names>J.</given-names></name><name><surname>Ludwiczuk</surname><given-names>A.</given-names></name><name><surname>Kowalczyk</surname><given-names>M.</given-names></name></person-group><article-title>Novel phenolic constituents of <italic>Pulmonaria officinalis</italic> L. LC-MS/MS comparison of spring and autumn metabolite profiles</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>2277</elocation-id></element-citation></ref><ref id="B17-molecules-26-00631"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keihanian</surname><given-names>F.</given-names></name><name><surname>Saeidinia</surname><given-names>A.</given-names></name><name><surname>Bagheri</surname><given-names>R.K.</given-names></name><name><surname>Johnston</surname><given-names>T.P.</given-names></name><name><surname>Sahebkar</surname><given-names>A.</given-names></name></person-group><article-title>Curcumin, hemostasis, thrombosis, and coagulation</article-title><source>J. Cell. Physiol.</source><year>2018</year><volume>233</volume><fpage>4497</fpage><lpage>4511</lpage><pub-id pub-id-type="doi">10.1002/jcp.26249</pub-id><pub-id pub-id-type="pmid">29052850</pub-id></element-citation></ref><ref id="B18-molecules-26-00631"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tressera-Rimbau</surname><given-names>A.</given-names></name><name><surname>Arranz</surname><given-names>S.</given-names></name><name><surname>Eder</surname><given-names>M.</given-names></name><name><surname>Vallverd&#x000fa;-Queralt</surname><given-names>A.</given-names></name></person-group><article-title>Dietary polyphenols in the prevention of stroke</article-title><source>Oxid. Med. Cell Longev.</source><year>2017</year><volume>2017</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1155/2017/7467962</pub-id></element-citation></ref><ref id="B19-molecules-26-00631"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adefegha</surname><given-names>S.A.</given-names></name></person-group><article-title>Functional foods and nutraceuticals as dietary intervention in chronic diseases; novel perspectives for health promotion and disease prevention</article-title><source>J. Diet. Suppl.</source><year>2018</year><volume>15</volume><fpage>977</fpage><lpage>1009</lpage><pub-id pub-id-type="doi">10.1080/19390211.2017.1401573</pub-id><pub-id pub-id-type="pmid">29281341</pub-id></element-citation></ref><ref id="B20-molecules-26-00631"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutcheson</surname><given-names>R.</given-names></name><name><surname>Rocic</surname><given-names>P.</given-names></name></person-group><article-title>The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: The great exploration</article-title><source>Exp. Diabetes Res.</source><year>2012</year><volume>2012</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1155/2012/271028</pub-id></element-citation></ref><ref id="B21-molecules-26-00631"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newsholme</surname><given-names>P.</given-names></name><name><surname>Cruzat</surname><given-names>V.F.</given-names></name><name><surname>Keane</surname><given-names>K.N.</given-names></name><name><surname>Carlessi</surname><given-names>R.</given-names></name><name><surname>de Bittencourt</surname><given-names>P.I.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Molecular mechanisms of ROS production and oxidative stress in diabetes</article-title><source>Biochem J.</source><year>2016</year><volume>473</volume><fpage>4527</fpage><lpage>4550</lpage><pub-id pub-id-type="doi">10.1042/BCJ20160503C</pub-id><pub-id pub-id-type="pmid">27941030</pub-id></element-citation></ref><ref id="B22-molecules-26-00631"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Redondo</surname><given-names>A.B.</given-names></name><name><surname>Aguado</surname><given-names>A.</given-names></name><name><surname>Briones</surname><given-names>A.M.</given-names></name><name><surname>Salaices</surname><given-names>M.</given-names></name></person-group><article-title>NADPH oxidases and vascular remodeling in cardiovascular diseases</article-title><source>Pharm. Res.</source><year>2016</year><volume>114</volume><fpage>110</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2016.10.015</pub-id><?supplied-pmid 27773825?><pub-id pub-id-type="pmid">27773825</pub-id></element-citation></ref><ref id="B23-molecules-26-00631"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panth</surname><given-names>N.</given-names></name><name><surname>Paudel</surname><given-names>K.R.</given-names></name><name><surname>Parajuli</surname><given-names>K.</given-names></name></person-group><article-title>Reactive oxygen species: Akeyhallmark of cardiovascular disease</article-title><source>Adv. Med.</source><year>2016</year><volume>2016</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1155/2016/9152732</pub-id><?supplied-pmid 27774507?><pub-id pub-id-type="pmid">27774507</pub-id></element-citation></ref><ref id="B24-molecules-26-00631"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname><given-names>P.</given-names></name><name><surname>Kossmann</surname><given-names>S.</given-names></name><name><surname>M&#x000fc;nzel</surname><given-names>T.</given-names></name><name><surname>Daiber</surname><given-names>A.</given-names></name></person-group><article-title>Redox regulation of cardiovascular inflammation&#x02013;immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species</article-title><source>Free Radic. Biol. Med.</source><year>2017</year><volume>109</volume><fpage>48</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2017.01.027</pub-id><?supplied-pmid 28108279?><pub-id pub-id-type="pmid">28108279</pub-id></element-citation></ref><ref id="B25-molecules-26-00631"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacher</surname><given-names>P.</given-names></name><name><surname>Beckman</surname><given-names>J.S.</given-names></name><name><surname>Liaudet</surname><given-names>L.</given-names></name></person-group><article-title>Nitric oxide and peroxynitrite in health and disease</article-title><source>Physiol. Rev.</source><year>2007</year><volume>87</volume><fpage>315</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1152/physrev.00029.2006</pub-id><?supplied-pmid 17237348?><pub-id pub-id-type="pmid">17237348</pub-id></element-citation></ref><ref id="B26-molecules-26-00631"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gole</surname><given-names>M.D.</given-names></name><name><surname>Souza</surname><given-names>J.M.</given-names></name><name><surname>Choi</surname><given-names>I.</given-names></name><name><surname>Hertkorn</surname><given-names>C.</given-names></name><name><surname>Malcolm</surname><given-names>S.</given-names></name><name><surname>Foust</surname><given-names>R.F.</given-names><suffix>III</suffix></name><name><surname>Finkel</surname><given-names>B.</given-names></name><name><surname>Lanken</surname><given-names>P.N.</given-names></name><name><surname>Ischiropoulos</surname><given-names>H.</given-names></name></person-group><article-title>Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome</article-title><source>Am. J. Physiol. Lung Cell. Mol. Physiol.</source><year>2000</year><volume>278</volume><fpage>961</fpage><lpage>967</lpage><pub-id pub-id-type="doi">10.1152/ajplung.2000.278.5.L961</pub-id><?supplied-pmid 10781426?><pub-id pub-id-type="pmid">10781426</pub-id></element-citation></ref><ref id="B27-molecules-26-00631"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vadseth</surname><given-names>C.</given-names></name><name><surname>Souza</surname><given-names>J.M.</given-names></name><name><surname>Thomson</surname><given-names>L.</given-names></name><name><surname>Seagraves</surname><given-names>A.</given-names></name><name><surname>Nagaswami</surname><given-names>C.</given-names></name><name><surname>Scheiner</surname><given-names>T.</given-names></name><name><surname>Torbet</surname><given-names>J.</given-names></name><name><surname>Vilaire</surname><given-names>G.</given-names></name><name><surname>Bennett</surname><given-names>J.</given-names></name><name><surname>Murciano</surname><given-names>J.-C.</given-names></name><etal/></person-group><article-title>Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. Nitrogen Species</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>8820</fpage><lpage>8826</lpage><pub-id pub-id-type="doi">10.1074/jbc.M306101200</pub-id><pub-id pub-id-type="pmid">14681238</pub-id></element-citation></ref><ref id="B28-molecules-26-00631"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lupidi</surname><given-names>G.</given-names></name><name><surname>Angeletti</surname><given-names>M.</given-names></name><name><surname>Eleuteri</surname><given-names>A.M.</given-names></name><name><surname>Tacconi</surname><given-names>L.</given-names></name><name><surname>Coletta</surname><given-names>M.</given-names></name><name><surname>Fioretti</surname><given-names>E.</given-names></name></person-group><article-title>Peroxynitrite-mediated oxidation of fibrinogen inhibits clot formation</article-title><source>FEBS Lett.</source><year>1999</year><volume>462</volume><fpage>236</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(99)01500-8</pub-id><pub-id pub-id-type="pmid">10622702</pub-id></element-citation></ref><ref id="B29-molecules-26-00631"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>V.G.</given-names></name><name><surname>Crow</surname><given-names>J.P.</given-names></name><name><surname>Zhou</surname><given-names>F.</given-names></name><name><surname>Parks</surname><given-names>D.C.</given-names></name></person-group><article-title>Peroxynitrite inactivates tissue plasminogen activator</article-title><source>Anesth. Analg.</source><year>2004</year><volume>98</volume><fpage>1312</fpage><lpage>1317</lpage><pub-id pub-id-type="doi">10.1213/01.ANE.0000111105.38836.F6</pub-id><pub-id pub-id-type="pmid">15105207</pub-id></element-citation></ref><ref id="B30-molecules-26-00631"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolodziejczyk-Czepas</surname><given-names>J.</given-names></name><name><surname>Ponczek</surname><given-names>M.B.</given-names></name><name><surname>Nowak</surname><given-names>P.</given-names></name></person-group><article-title>Peroxynitrite and fibrinolytic system&#x02014;The effects of peroxynitrite on t-PA-induced plasmin activity</article-title><source>Int. J. Biol. Macromol.</source><year>2015</year><volume>81</volume><fpage>212</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2015.07.059</pub-id><pub-id pub-id-type="pmid">26234576</pub-id></element-citation></ref><ref id="B31-molecules-26-00631"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krzy&#x0017c;anowska-Kowalczyk</surname><given-names>J.</given-names></name><name><surname>Kolodziejczyk-Czepas</surname><given-names>J.</given-names></name><name><surname>Kowalczyk</surname><given-names>M.</given-names></name><name><surname>Pecio</surname><given-names>&#x00141;.</given-names></name><name><surname>Nowak</surname><given-names>P.</given-names></name><name><surname>Stochmal</surname><given-names>A.</given-names></name></person-group><article-title>Yunnaneic acid B&#x02013;a component of <italic>Pulmonaria officinalis</italic> extract prevents the peroxynitrite-induced oxidative stress in vitro</article-title><source>J. Agric. Food Chem.</source><year>2017</year><volume>65</volume><fpage>3827</fpage><lpage>3834</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.7b00718</pub-id><pub-id pub-id-type="pmid">28453265</pub-id></element-citation></ref><ref id="B32-molecules-26-00631"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habu</surname><given-names>J.B.</given-names></name><name><surname>Ibeh</surname><given-names>B.O.</given-names></name></person-group><article-title>In vitro antioxidant capacity and free radical scavenging evaluation of active metabolite constituents of <italic>Newbouldialaevis</italic> ethanolic leaf extract</article-title><source>Biol. Res.</source><year>2015</year><volume>48</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/s40659-015-0007-x</pub-id><?supplied-pmid 25849161?><pub-id pub-id-type="pmid">25849161</pub-id></element-citation></ref><ref id="B33-molecules-26-00631"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>Hazra</surname><given-names>B.</given-names></name><name><surname>Mandal</surname><given-names>N.</given-names></name><name><surname>Chaudhuri</surname><given-names>T.K.</given-names></name></person-group><article-title>Assessment of the antioxidant and free radical scavenging activities of methanolic extract of <italic>Diplaziumesculentum</italic></article-title><source>Int. J. Food Prop.</source><year>2013</year><volume>16</volume><fpage>1351</fpage><lpage>1370</lpage><pub-id pub-id-type="doi">10.1080/10942912.2011.587382</pub-id></element-citation></ref><ref id="B34-molecules-26-00631"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckmann</surname><given-names>J.S.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Ischiropoulos</surname><given-names>H.</given-names></name><name><surname>Crow</surname><given-names>J.P.</given-names></name></person-group><article-title>Oxidative chemistry of peroxynitrite</article-title><source>Methods Enzym.</source><year>1994</year><volume>233</volume><fpage>229</fpage><lpage>240</lpage></element-citation></ref><ref id="B35-molecules-26-00631"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alagawany</surname><given-names>M.</given-names></name><name><surname>Abd El-Hack</surname><given-names>M.E.</given-names></name><name><surname>Farag</surname><given-names>M.R.</given-names></name><name><surname>Gopi</surname><given-names>M.</given-names></name><name><surname>Karthik</surname><given-names>K.</given-names></name><name><surname>Malik</surname><given-names>Y.S.</given-names></name><name><surname>Dhama</surname><given-names>K.</given-names></name></person-group><article-title>Rosmarinic acid: Modes of action, medicinal values and health benefits</article-title><source>Anim. Health Res. Rev.</source><year>2017</year><volume>18</volume><fpage>167</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1017/S1466252317000081</pub-id><?supplied-pmid 29110743?><pub-id pub-id-type="pmid">29110743</pub-id></element-citation></ref><ref id="B36-molecules-26-00631"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Tsubouchi</surname><given-names>R.</given-names></name><name><surname>Haneda</surname><given-names>M.</given-names></name><name><surname>Murakami</surname><given-names>K.</given-names></name><name><surname>Takeuchi</surname><given-names>F.</given-names></name><name><surname>Nisimoto</surname><given-names>Y.</given-names></name><name><surname>Yoshino</surname><given-names>M.</given-names></name></person-group><article-title>Rosmarinic acid inhibits the formation of reactive oxygen and nitrogen species in RAW264.7 macrophages</article-title><source>Free Radic Res.</source><year>2005</year><volume>39</volume><fpage>995</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1080/10715760500231836</pub-id><pub-id pub-id-type="pmid">16087481</pub-id></element-citation></ref><ref id="B37-molecules-26-00631"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ondua</surname><given-names>M.</given-names></name><name><surname>Adebayo</surname><given-names>S.A.</given-names></name><name><surname>Shai</surname><given-names>L.J.</given-names></name><name><surname>Lebelo</surname><given-names>S.L.</given-names></name></person-group><article-title>The anti-inflammatory and anti-nociceptive activities of some medicinal plant species used to treat inflammatory pain conditions in Southern Africa</article-title><source>Int. J. Pharm. Phytochem. Res.</source><year>2016</year><volume>8</volume><fpage>1571</fpage><lpage>1575</lpage></element-citation></ref><ref id="B38-molecules-26-00631"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>J.L.S.</given-names></name><name><surname>van Staden</surname><given-names>J.</given-names></name></person-group><article-title>COX-1 and COX-2 inhibitory activity in extracts prepared from <italic>Eucomis</italic> species, with further reference to extracts from <italic>E. autumnalisautumnalis</italic></article-title><source>S. Afr. J. Bot.</source><year>2002</year><volume>68</volume><fpage>80</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/S0254-6299(16)30460-4</pub-id></element-citation></ref><ref id="B39-molecules-26-00631"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paun</surname><given-names>G.</given-names></name><name><surname>Neagu</surname><given-names>E.</given-names></name><name><surname>Moroeanu</surname><given-names>V.</given-names></name><name><surname>Albu</surname><given-names>C.</given-names></name><name><surname>Ursu</surname><given-names>T.M.</given-names></name><name><surname>Zanfirescu</surname><given-names>A.</given-names></name><name><surname>Negres</surname><given-names>S.</given-names></name><name><surname>Chirita</surname><given-names>C.</given-names></name><name><surname>Radu</surname><given-names>G.L.</given-names></name></person-group><article-title>Anti-inflammatory and antioxidant activities of the <italic>Impatiens noli-tangere</italic> and <italic>Stachys officinalis</italic> polyphenolic-rich extracts</article-title><source>Rev. Bras. Farm.</source><year>2018</year><volume>28</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.bjp.2017.10.008</pub-id></element-citation></ref><ref id="B40-molecules-26-00631"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colica</surname><given-names>C.</given-names></name><name><surname>Di Renzo</surname><given-names>L.</given-names></name><name><surname>Aiello</surname><given-names>V.</given-names></name><name><surname>De Lorenzo</surname><given-names>A.</given-names></name><name><surname>Abenavoli</surname><given-names>L.</given-names></name></person-group><article-title>Rosmarinicacid as potential anti-inflammatory agent</article-title><source>Rev. Recent Clin. Trials</source><year>2018</year><volume>13</volume><fpage>240</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.2174/157488711304180911095818</pub-id><pub-id pub-id-type="pmid">30328397</pub-id></element-citation></ref><ref id="B41-molecules-26-00631"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>S.J.</given-names></name><name><surname>Kim</surname><given-names>Y.W.</given-names></name><name><surname>Park</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>K.W.</given-names></name></person-group><article-title>Anti-inflammatory effects of chlorogenic acid in lipopolysaccharide-stimulated RAW 264.7 cells</article-title><source>Inflamm. Res.</source><year>2014</year><volume>63</volume><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1007/s00011-013-0674-4</pub-id><pub-id pub-id-type="pmid">24127072</pub-id></element-citation></ref><ref id="B42-molecules-26-00631"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murata</surname><given-names>T.</given-names></name><name><surname>Oyama</surname><given-names>K.</given-names></name><name><surname>Fujiyama</surname><given-names>M.</given-names></name><name><surname>Oobayashi</surname><given-names>B.</given-names></name><name><surname>Umehara</surname><given-names>K.</given-names></name><name><surname>Miyase</surname><given-names>T.</given-names></name><name><surname>Yoshizaki</surname><given-names>F.</given-names></name></person-group><article-title>Diastereomers of lithospermic acid and lithospermic acid B from <italic>Monarda fistulosa</italic> and <italic>Lithospermumerythrorhizon</italic></article-title><source>Fitoterapia</source><year>2013</year><volume>91</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2013.08.009</pub-id><?supplied-pmid 23978578?><pub-id pub-id-type="pmid">23978578</pub-id></element-citation></ref><ref id="B43-molecules-26-00631"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>H.G.</given-names></name><name><surname>Tran</surname><given-names>P.T.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Min</surname><given-names>B.S.</given-names></name><name><surname>Kim</surname><given-names>J.A.</given-names></name></person-group><article-title>Anti-inflammatory activity of caffeic acid derivatives isolated from the roots of <italic>Salvia miltiorrhiza</italic> Bunge</article-title><source>Arch. Pharm. Res.</source><year>2018</year><volume>41</volume><fpage>64</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1007/s12272-017-0983-1</pub-id><?supplied-pmid 29124660?><pub-id pub-id-type="pmid">29124660</pub-id></element-citation></ref><ref id="B44-molecules-26-00631"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muhammad</surname><given-names>A.</given-names></name><name><surname>Sirat</surname><given-names>H.M.</given-names></name></person-group><article-title>COX-2 inhibitors from stem bark of <italic>Bauhinia rufescens</italic> Lam. (Fabaceae)</article-title><source>Excli J.</source><year>2013</year><volume>12</volume><fpage>824</fpage><lpage>830</lpage><?supplied-pmid 26600739?><pub-id pub-id-type="pmid">26600739</pub-id></element-citation></ref><ref id="B45-molecules-26-00631"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryor</surname><given-names>W.A.</given-names></name><name><surname>Cueto</surname><given-names>R.</given-names></name><name><surname>Jin</surname><given-names>X.</given-names></name><name><surname>Koppenol</surname><given-names>W.H.</given-names></name><name><surname>Ngu-Schwemlein</surname><given-names>M.</given-names></name><name><surname>Squadrito</surname><given-names>G.</given-names></name><name><surname>Uppu</surname><given-names>P.L.</given-names></name><name><surname>Uppu</surname><given-names>R.M.</given-names></name></person-group><article-title>A practical method for preparing peroxynitrite solutions of low ionic strength and free of hydrogen peroxide</article-title><source>Free Radic. Biol. Med.</source><year>1991</year><volume>1</volume><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/0891-5849(94)00105-S</pub-id></element-citation></ref><ref id="B46-molecules-26-00631"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolodziejczyk-Czepas</surname><given-names>J.</given-names></name><name><surname>Krzy&#x0017c;anowska-Kowalczyk</surname><given-names>J.</given-names></name><name><surname>Sieradzka</surname><given-names>M.</given-names></name><name><surname>Nowak</surname><given-names>P.</given-names></name><name><surname>Stochmal</surname><given-names>A.</given-names></name></person-group><article-title>Clovamide and clovamide-rich extracts of three <italic>Trifolium</italic> species as antioxidants and moderate antiplatelet agents in vitro</article-title><source>Phytochemistry</source><year>2017</year><volume>143</volume><fpage>54</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2017.07.011</pub-id><pub-id pub-id-type="pmid">28777978</pub-id></element-citation></ref><ref id="B47-molecules-26-00631"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janaszewska</surname><given-names>A.</given-names></name><name><surname>Bartosz</surname><given-names>G.</given-names></name></person-group><article-title>Assay of total antioxidant capacity: Comparison of four methods as applied to human blood plasma</article-title><source>Scand J. Clin. Lab. Investig.</source><year>2002</year><volume>62</volume><fpage>231</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1080/003655102317475498</pub-id><pub-id pub-id-type="pmid">12088342</pub-id></element-citation></ref><ref id="B48-molecules-26-00631"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gay</surname><given-names>C.</given-names></name><name><surname>Gebicki</surname><given-names>J.M.</given-names></name></person-group><article-title>A critical evaluation of the effect of sorbitol on the ferric-xylenol orange hydroperoxide assay</article-title><source>Anal. Biochem.</source><year>2000</year><volume>284</volume><fpage>217</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1006/abio.2000.4696</pub-id><pub-id pub-id-type="pmid">10964403</pub-id></element-citation></ref><ref id="B49-molecules-26-00631"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wachowicz</surname><given-names>B.</given-names></name></person-group><article-title>Adenine nucleotides in thrombocytes of birds</article-title><source>Cell Biochem. Funct.</source><year>1984</year><volume>2</volume><fpage>167</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1002/cbf.290020310</pub-id><pub-id pub-id-type="pmid">6478540</pub-id></element-citation></ref><ref id="B50-molecules-26-00631"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olas</surname><given-names>B.</given-names></name><name><surname>Nowak</surname><given-names>P.</given-names></name><name><surname>Kolodziejczyk</surname><given-names>J.</given-names></name><name><surname>Wachowicz</surname><given-names>B.</given-names></name></person-group><article-title>The effects of antioxidants on peroxynitrite-induced changes in platelet proteins</article-title><source>Thromb. Res.</source><year>2004</year><volume>113</volume><fpage>399</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.thromres.2004.04.002</pub-id><pub-id pub-id-type="pmid">15226095</pub-id></element-citation></ref><ref id="B51-molecules-26-00631"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bijak</surname><given-names>M.</given-names></name><name><surname>Saluk</surname><given-names>J.</given-names></name><name><surname>Tsirigotis-Maniecka</surname><given-names>M.</given-names></name><name><surname>Komorowska</surname><given-names>H.</given-names></name><name><surname>Wachowicz</surname><given-names>B.</given-names></name><name><surname>Zaczy&#x00144;ska</surname><given-names>E.</given-names></name><name><surname>Czarny</surname><given-names>A.</given-names></name><name><surname>Czechowski</surname><given-names>F.</given-names></name><name><surname>Nowak</surname><given-names>P.</given-names></name><name><surname>Pawlaczyk</surname><given-names>I.</given-names></name></person-group><article-title>The influence of conjugatesisolated from <italic>Matricariachamomilla</italic> L. on plateletsactivity and cytotoxicity</article-title><source>Int. J. Biol. Macromol.</source><year>2013</year><volume>61</volume><fpage>218</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2013.06.046</pub-id><pub-id pub-id-type="pmid">23831537</pub-id></element-citation></ref><ref id="B52-molecules-26-00631"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trott</surname><given-names>O.</given-names></name><name><surname>Olson</surname><given-names>A.J.J.</given-names></name></person-group><article-title>AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</article-title><source>Comput. Chem.</source><year>2010</year><volume>31</volume><fpage>455</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1002/jcc.21334</pub-id><?supplied-pmid 19499576?><pub-id pub-id-type="pmid">19499576</pub-id></element-citation></ref><ref id="B53-molecules-26-00631"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurumbail</surname><given-names>R.G.</given-names></name><name><surname>Stevens</surname><given-names>A.M.</given-names></name><name><surname>Gierse</surname><given-names>J.K.</given-names></name><name><surname>McDonald</surname><given-names>J.J.</given-names></name><name><surname>Stegeman</surname><given-names>R.A.</given-names></name><name><surname>Pak</surname><given-names>J.Y.</given-names></name><name><surname>Gildehaus</surname><given-names>D.</given-names></name><name><surname>Miyashiro</surname><given-names>J.M.</given-names></name><name><surname>Penning</surname><given-names>T.D.</given-names></name><name><surname>Seibert</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents</article-title><source>Nature</source><year>1996</year><volume>384</volume><fpage>644</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1038/384644a0</pub-id><?supplied-pmid 8967954?><pub-id pub-id-type="pmid">8967954</pub-id></element-citation></ref><ref id="B54-molecules-26-00631"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanwell</surname><given-names>M.D.</given-names></name><name><surname>Curtis</surname><given-names>D.E.</given-names></name><name><surname>Lonie</surname><given-names>D.C.</given-names></name><name><surname>Vandermeersch</surname><given-names>T.</given-names></name><name><surname>Zurek</surname><given-names>E.</given-names></name><name><surname>Hutchison</surname><given-names>G.R.J.</given-names></name></person-group><article-title>Avogadro: An advanced semantic chemical editor, visualization, and analysis platform</article-title><source>J. Cheminf.</source><year>2012</year><pub-id pub-id-type="doi">10.1186/1758-2946-4-17</pub-id><?supplied-pmid 22889332?><pub-id pub-id-type="pmid">22889332</pub-id></element-citation></ref><ref id="B55-molecules-26-00631"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halgren</surname><given-names>T.A.J.</given-names></name></person-group><article-title>Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</article-title><source>Comput. Chem.</source><year>1996</year><volume>17</volume><fpage>490</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199604)17:5/6&#x0003c;490::AID-JCC1&#x0003e;3.0.CO;2-P</pub-id></element-citation></ref><ref id="B56-molecules-26-00631"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>G.M.</given-names></name><name><surname>Huey</surname><given-names>R.</given-names></name><name><surname>Lindstrom</surname><given-names>W.</given-names></name><name><surname>Sanner</surname><given-names>M.F.</given-names></name><name><surname>Belew</surname><given-names>R.K.</given-names></name><name><surname>Goodsell</surname><given-names>D.S.</given-names></name><name><surname>Olson</surname><given-names>A.J.J.</given-names></name></person-group><article-title>AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility</article-title><source>Comput. Chem.</source><year>2009</year><volume>30</volume><fpage>2785</fpage><lpage>2791</lpage><pub-id pub-id-type="doi">10.1002/jcc.21256</pub-id><?supplied-pmid 19399780?><pub-id pub-id-type="pmid">19399780</pub-id></element-citation></ref><ref id="B57-molecules-26-00631"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>E.F.</given-names></name><name><surname>Goddard</surname><given-names>T.D.</given-names></name><name><surname>Huang</surname><given-names>C.C.</given-names></name><name><surname>Couch</surname><given-names>G.S.</given-names></name><name><surname>Greenblatt</surname><given-names>D.M.</given-names></name><name><surname>Meng</surname><given-names>E.C.</given-names></name><name><surname>Ferrin</surname><given-names>T.E.J.</given-names></name></person-group><article-title>UCSF Chimera -a visualization system for exploratory research and analysis</article-title><source>Comput. Chem.</source><year>2004</year><volume>25</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-26-00631-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Chromatographic profile of <italic>Pulmonaria obscura</italic> and <italic>Pulmonaria officinalis</italic> phenolic-rich fractions (signal form charged aerosol detector, numbers indicate compounds that were characterized and quantitatively analyzed, IS&#x02013;internal standard).</p></caption><graphic xlink:href="molecules-26-00631-g001"/></fig><fig id="molecules-26-00631-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Protective effect of the examined <italic>Pulmonaria</italic> extracts (50% methanolic fractions) on the non-enzymatic antioxidant capacity of blood plasma under the 150 &#x000b5;M ONOO<sup>&#x02212;</sup>-induced oxidative stress. The assay was based on DPPH<sup>&#x02022;</sup> radical scavenging ability as a biomarker of the non-enzymatic antioxidant capacity of blood plasma. DPPH-scavenging efficiency of control (untreated) plasma was assumed as 100% of NEAC; (* <italic>p</italic> &#x0003c; 0.05; *** <italic>p</italic> &#x0003c; 0.001 for plasma treated with ONOO<sup>&#x02212;</sup> in the absence of examined substances versus plasma treated with ONOO<sup>&#x02212;</sup> in the presence of the extracts; <sup>#</sup>
<italic>p</italic> &#x0003c; 0.05 for the control plasma vs. samples treated with ONOO<sup>&#x02212;</sup> in the absence of examined substances; <italic>n</italic> = 6).</p></caption><graphic xlink:href="molecules-26-00631-g002"/></fig><fig id="molecules-26-00631-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>The molecular docking of menisdaurin (<bold>C</bold>) and salvianolic acid H (<bold>B</bold>) with comparison to reference compound indomethacin (<bold>A</bold>), according to its crystal localization.</p></caption><graphic xlink:href="molecules-26-00631-g003"/></fig><table-wrap id="molecules-26-00631-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00631-t001_Table 1</object-id><label>Table 1</label><caption><p>Phytochemical composition of the examined phenolic-rich fractions isolated from <italic>P. obscura</italic> and <italic>P. officinalis</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Content of Phytochemicals (% of the Fraction)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>P. obscura</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>P. officinalis</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Phenolic acids</td><td align="center" valign="middle" rowspan="1" colspan="1">81.01</td><td align="center" valign="middle" rowspan="1" colspan="1">81.15</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lignans</td><td align="center" valign="middle" rowspan="1" colspan="1">11.27</td><td align="center" valign="middle" rowspan="1" colspan="1">6.46</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Flavonol glycosides</td><td align="center" valign="middle" rowspan="1" colspan="1">4.95</td><td align="center" valign="middle" rowspan="1" colspan="1">5.16</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Others</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.22</td></tr></tbody></table></table-wrap><table-wrap id="molecules-26-00631-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00631-t002_Table 2</object-id><label>Table 2</label><caption><p>Metabolite content in the examined phenolic-rich fractions, isolated from aerial parts of <italic>P. obscura</italic> and <italic>P. officinalis</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">No.</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Compound Name</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Contents [&#x000b5;g/mg of Fraction] (Mean &#x000b1; SD, <italic>n</italic> = 3)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. obscura</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. officinalis</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">Danshensu</td><td align="center" valign="middle" rowspan="1" colspan="1">2.40 &#x000b1; 0.10</td><td align="center" valign="middle" rowspan="1" colspan="1">1.52 &#x000b1; 0.06</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">Menisdaurin</td><td align="center" valign="middle" rowspan="1" colspan="1">16.36 &#x000b1; 0.43</td><td align="center" valign="middle" rowspan="1" colspan="1">39.08 &#x000b1; 1.56</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3-<italic>O</italic>-(<italic>E</italic>)-caffeoyl-threonic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">1.18 &#x000b1; 0.10</td><td align="center" valign="middle" rowspan="1" colspan="1">1.53 &#x000b1; 0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">2-<italic>O</italic>-(<italic>E</italic>)-caffeoyl-<sc>l</sc>-threonic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">3.34 &#x000b1; 0.11</td><td align="center" valign="middle" rowspan="1" colspan="1">4.52 &#x000b1; 0.14</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">Lycoperodine-1</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">1.20 &#x000b1; 0.04</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">Chlorogenic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">4.87 &#x000b1; 0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">4.32 &#x000b1; 0.11</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">Actinidioionoside</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">Caffeic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">2.31 &#x000b1; 0.11</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">Cryptochlorogenic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">0.74 &#x000b1; 0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22 &#x000b1; 0.01</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">3&#x02019;-<italic>O</italic>-(<italic>E</italic>)-feruloyl-&#x003b1;-sorbopyranosyl-(2&#x02019;&#x02192;1)-&#x003b1;-glucopyranoside</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">0.45 &#x000b1; 0.01</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">2-<italic>O</italic>-(<italic>E</italic>)-caffeoyl-<sc>d</sc>-glyceric acid</td><td align="center" valign="middle" rowspan="1" colspan="1">1.24 &#x000b1; 0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">5.10 &#x000b1; 0.14</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">4-<italic>O</italic>-(<italic>E</italic>)-caffeoyl-<sc>l</sc>-threonic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">1.50 &#x000b1; 0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">2.78 &#x000b1; 0.07</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">Neochlorogenic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">0.37 &#x000b1; 0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04 &#x000b1; 0.00</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">3-<italic>O</italic>-(<italic>E</italic>)-caffeoyl-glyceric acid</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">2.08 &#x000b1; 0.06</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">3-<italic>O</italic>-<italic>p</italic>-coumaroylquinic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">0.87 &#x000b1; 0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">2.29 &#x000b1; 0.04</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">4-<italic>O</italic>-<italic>p</italic>-coumaroylquinic acid </td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">5<italic>-O</italic>-<italic>p</italic>-coumaroylquinic acid </td><td align="center" valign="middle" rowspan="1" colspan="1">0.93 &#x000b1; 0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">1.88 &#x000b1; 0.04</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">Globoidnan B</td><td align="center" valign="middle" rowspan="1" colspan="1">29.79 &#x000b1; 4.46</td><td align="center" valign="middle" rowspan="1" colspan="1">24.16 &#x000b1; 3.33</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">Rutin</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">Nicotiflorin isomer</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin 3-<italic>O</italic>-<italic>&#x003b2;</italic>-glucoside</td><td align="center" valign="middle" rowspan="1" colspan="1">0.62 &#x000b1; 0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.33 &#x000b1; 0.02</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">Yunnaneic acid E</td><td align="center" valign="middle" rowspan="1" colspan="1">27.32 &#x000b1; 0.23</td><td align="center" valign="middle" rowspan="1" colspan="1">12.07 &#x000b1; 0.33</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin 3-<italic>O</italic>-(6&#x02032;&#x02032;-<italic>O</italic>-malonyl)-<italic>&#x003b2;</italic>-glucoside</td><td align="center" valign="middle" rowspan="1" colspan="1">4.10 &#x000b1; 0.18</td><td align="center" valign="middle" rowspan="1" colspan="1">2.82 &#x000b1; 0.15</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">Nicotiflorin</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">Astragalin</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">Shimobashiric acid C</td><td align="center" valign="middle" rowspan="1" colspan="1">7.46 &#x000b1; 0.17</td><td align="center" valign="middle" rowspan="1" colspan="1">5.46 &#x000b1; 0.17</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">Rosmarinic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">301.46 &#x000b1; 35.04</td><td align="center" valign="middle" rowspan="1" colspan="1">159.28 &#x000b1; 17.09</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="center" valign="middle" rowspan="1" colspan="1">Kaempferol 3<italic>-O</italic>-(6&#x02032;&#x02032;-<italic>O</italic>-malonyl)-<italic>&#x003b2;</italic>-glucoside</td><td align="center" valign="middle" rowspan="1" colspan="1">0.40 &#x000b1; 0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">Monardic acid A</td><td align="center" valign="middle" rowspan="1" colspan="1">42.99 &#x000b1; 5.04</td><td align="center" valign="middle" rowspan="1" colspan="1">17.56 &#x000b1; 2.77</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">Yunnaneic acid E-1</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">31</td><td align="center" valign="middle" rowspan="1" colspan="1">Lithospermic acid A</td><td align="center" valign="middle" rowspan="1" colspan="1">80.13 &#x000b1;6.44</td><td align="center" valign="middle" rowspan="1" colspan="1">44.20 &#x000b1; 0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">32</td><td align="center" valign="middle" rowspan="1" colspan="1">Pulmonarioside A</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">33</td><td align="center" valign="middle" rowspan="1" colspan="1">Salvianolic acid H</td><td align="center" valign="middle" rowspan="1" colspan="1">8.97 &#x000b1; 0.82</td><td align="center" valign="middle" rowspan="1" colspan="1">26.23 &#x000b1; 0.75</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">34</td><td align="center" valign="middle" rowspan="1" colspan="1">Lithospermic acid B</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">35</td><td align="center" valign="middle" rowspan="1" colspan="1">Pulmonarioside B</td><td align="center" valign="middle" rowspan="1" colspan="1">0.50 &#x000b1; 0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">Yunnaneic acid B</td><td align="center" valign="middle" rowspan="1" colspan="1">23.65 &#x000b1; 0.52</td><td align="center" valign="middle" rowspan="1" colspan="1">22.65 &#x000b1; 1.49</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">37</td><td align="center" valign="middle" rowspan="1" colspan="1">Globoidnan A</td><td align="center" valign="middle" rowspan="1" colspan="1">4.10 &#x000b1; 0.17</td><td align="center" valign="middle" rowspan="1" colspan="1">0.57 &#x000b1; 0.02</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">38</td><td align="center" valign="middle" rowspan="1" colspan="1">Pulmitric acid A</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">39</td><td align="center" valign="middle" rowspan="1" colspan="1">Pulmitric acid B</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">Isosalvianolic acid A</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">41</td><td align="center" valign="middle" rowspan="1" colspan="1">Isosalvianolic acid A-1</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">42</td><td align="center" valign="middle" rowspan="1" colspan="1">Isosalvianolic acid A isomer</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">43</td><td align="center" valign="middle" rowspan="1" colspan="1">Rosmarinic acid methyl ester</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td><td align="center" valign="middle" rowspan="1" colspan="1">Traces</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">44</td><td align="center" valign="middle" rowspan="1" colspan="1">Salvianolic acid H-9&#x02032;&#x02032;-methylester</td><td align="center" valign="middle" rowspan="1" colspan="1">3.87 &#x000b1; 0.11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.79 &#x000b1; 0.02</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lycopic acid C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn><p>TR&#x02013;traces, indicates level below the limit of quantification, NA&#x02013;not analyzed, ND&#x02013;not detected.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-26-00631-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00631-t003_Table 3</object-id><label>Table 3</label><caption><p>Determination of the ONOO<sup>&#x02212;</sup> scavenging abilities of <italic>P. obscura</italic> and <italic>P. officinalis</italic> phenolic-rich fractions, based on their inhibitory effects on the 1 mM ONOO<sup>&#x02212;</sup>-induced bleaching (peroxidation) of Evans blue dye (<italic>n</italic> = 4&#x02013;6).</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Inhibition of the ONOO<sup>&#x02212;</sup>-Induced Evans Blue Peroxidation</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub> [&#x000b5;g/mL]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>P. obscura</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">36.71</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>P. officinalis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">32.66</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rosmarinic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">13.34</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trolox</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.76</td></tr></tbody></table></table-wrap><table-wrap id="molecules-26-00631-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00631-t004_Table 4</object-id><label>Table 4</label><caption><p>Protective effects of the examined <italic>Pulmonaria</italic> phenolic-rich fractions on the 100 &#x000b5;M ONOO<sup>&#x02212;</sup>-induced nitration of tyrosine residues in human blood plasma proteins and the isolated human fibrinogen (* <italic>p</italic> &#x0003c; 0.05; ** <italic>p</italic> &#x0003c; 0.01; *** <italic>p</italic> &#x0003c; 0.001 for plasma treated with ONOO<sup>&#x02212;</sup> in the absence of examined substances vs. plasma treated with ONOO<sup>&#x02212;</sup> in the presence of the extracts; <sup>###</sup>
<italic>p</italic> &#x0003c; 0.001 for the control samples vs. samples treated with ONOO<sup>&#x02212;</sup> in the absence of examined substances; /-per; <italic>n</italic> = 7).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin"><italic>Pulmonaria</italic> Phenolic-Rich Fractions and Reference Compounds [&#x000b5;g/mL]</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">3-Nitrotyrosine [nmol 3-NT-Fg/mg of Protein]</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isolated Fibrinogen</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blood Plasma</th></tr></thead><tbody><tr><td colspan="2" align="center" valign="middle" rowspan="1">control (untreated) samples</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.006 &#x000b1; 0.003</td><td align="center" valign="middle" rowspan="1" colspan="1">0.026 &#x000b1; 0.008</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">samples treated with ONOO<sup>&#x02212;</sup> in the absence of examined substances</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.326 &#x000b1; 0.072 <sup>###</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.605 &#x000b1; 0.392 <sup>###</sup></td></tr><tr><td rowspan="12" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">samples treated with ONOO<sup>&#x02212;</sup> in the presence of:</td><td rowspan="5" align="center" valign="middle" colspan="1">
<italic>P. obscura</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.357 &#x000b1; 0.058</td><td align="center" valign="middle" rowspan="1" colspan="1">2.152 &#x000b1; 0.640</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">1.200 &#x000b1; 0.158</td><td align="center" valign="middle" rowspan="1" colspan="1">2.040 &#x000b1; 0.520</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">0.889 &#x000b1; 0.259 **</td><td align="center" valign="middle" rowspan="1" colspan="1">1.881 &#x000b1; 0.709 **</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">50</td><td align="center" valign="middle" rowspan="1" colspan="1">0.785 &#x000b1; 0.354 *</td><td align="center" valign="middle" rowspan="1" colspan="1">1.590 &#x000b1; 0.562 ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">0.620 &#x000b1; 0.459 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">1.060 &#x000b1; 0.539 ***</td></tr><tr><td rowspan="5" align="center" valign="middle" colspan="1">
<italic>P. officinalis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.257 &#x000b1; 0.111</td><td align="center" valign="middle" rowspan="1" colspan="1">2.070 &#x000b1; 0.207 **</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">1.106 &#x000b1; 0.279</td><td align="center" valign="middle" rowspan="1" colspan="1">2.335 &#x000b1; 0.379</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">0.895 &#x000b1; 0.244 *</td><td align="center" valign="middle" rowspan="1" colspan="1">2.301 &#x000b1; 0.559</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">50</td><td align="center" valign="middle" rowspan="1" colspan="1">0.917 &#x000b1; 0.280 *</td><td align="center" valign="middle" rowspan="1" colspan="1">1.342 &#x000b1; 0.401 **</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">0.799 &#x000b1; 0.387 **</td><td align="center" valign="middle" rowspan="1" colspan="1">0.943 &#x000b1; 0.317 ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rosmarinic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.803 &#x000b1; 0.411 **</td><td align="center" valign="middle" rowspan="1" colspan="1">2.069 &#x000b1; 0.308 **</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trolox</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.898 &#x000b1; 0.328 *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.788 &#x000b1; 0.793 **</td></tr></tbody></table></table-wrap><table-wrap id="molecules-26-00631-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00631-t005_Table 5</object-id><label>Table 5</label><caption><p>Protective effect of <italic>Pulmonaria</italic> phenolic-rich fractions on the 100 &#x000b5;M ONOO<sup>&#x02212;</sup>-induced peroxidation of blood plasma lipids. The peroxidation of blood plasma lipids in samples treated with ONOO<sup>&#x02212;</sup> in the absence of the examined substances was assumed as 100% of lipid peroxidation (* <italic>p</italic> &#x0003c; 0.05; ** <italic>p</italic> &#x0003c; 0.01; *** <italic>p</italic> &#x0003c; 0.001; <italic>n</italic> = 8).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin"><italic>Pulmonaria</italic> Phenolic-Rich Fractions and Reference Compounds [&#x000b5;g/mL]</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Plasma Lipid Peroxidation Biomarkers</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">% of Lipid Hydroperoxides<break/>Generation</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">% of TBARS<break/>Formation</th></tr></thead><tbody><tr><td rowspan="12" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">plasma treated with ONOO<sup>&#x02212;</sup> in the presence of:</td><td rowspan="5" align="center" valign="middle" colspan="1">
<italic>P. obscura</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">72.924 &#x000b1; 6.660 **</td><td align="center" valign="middle" rowspan="1" colspan="1">96.234 &#x000b1; 6.746</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">65.102 &#x000b1; 6.242 **</td><td align="center" valign="middle" rowspan="1" colspan="1">83.308 &#x000b1; 8.987 *</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">54.075 &#x000b1; 5.957 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">71.977 &#x000b1; 14.638 *</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">50</td><td align="center" valign="middle" rowspan="1" colspan="1">54.983 &#x000b1; 6.966 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">62.389 &#x000b1; 10.826 ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">53.805 &#x000b1; 9.557 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">63.759 &#x000b1; 9.306 ***</td></tr><tr><td rowspan="5" align="center" valign="middle" colspan="1">
<italic>P. officinalis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">75.492 &#x000b1; 6.788 **</td><td align="center" valign="middle" rowspan="1" colspan="1">84.685 &#x000b1; 13.169</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">70.085 &#x000b1; 6.394 **</td><td align="center" valign="middle" rowspan="1" colspan="1">79.188 &#x000b1; 11.122 *</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">59.695 &#x000b1; 5.208 **</td><td align="center" valign="middle" rowspan="1" colspan="1">75.782 &#x000b1; 10.019 *</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">50</td><td align="center" valign="middle" rowspan="1" colspan="1">59.927 &#x000b1; 8.141 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">66.851 &#x000b1; 12.462 **</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">57.126 &#x000b1; 8.145 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">57.746 &#x000b1; 8.855 ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rosmarinic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">58.246 &#x000b1; 14.864 **</td><td align="center" valign="middle" rowspan="1" colspan="1">67.552 &#x000b1; 11.641 **</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trolox</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">63.986 &#x000b1; 7.585 ***</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">69.212 &#x000b1; 11.459 ***</td></tr></tbody></table></table-wrap><table-wrap id="molecules-26-00631-t006" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00631-t006_Table 6</object-id><label>Table 6</label><caption><p>The IC<sub>50</sub> values established during a screening of inhibitory actions of <italic>P. obscura</italic> and <italic>P. officinalis</italic> phenolic-rich fractions on COX-2 activity (<italic>n</italic> = 3&#x02013;4).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">The Examined Substances</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">IC<sub>50</sub> [&#x000b5;g/mL]</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The PGF<sub>2&#x003b1;</sub>Generation (ELISA)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The Oxidation of Chromogenic Substrate (Colorimetric Assay)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>P. obscura</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">51.00</td><td align="center" valign="middle" rowspan="1" colspan="1">58.59</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>P. officinalis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">7.24</td><td align="center" valign="middle" rowspan="1" colspan="1">13.28</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Indomethacin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.06</td></tr></tbody></table></table-wrap><table-wrap id="molecules-26-00631-t007" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00631-t007_Table 7</object-id><label>Table 7</label><caption><p>Assessment of cytotoxicity of the examined <italic>Pulmonaria</italic> phenolic-rich fractions towards peripheral blood mononuclear cells and blood platelets in vitro. Viability of control (untreated) PBMCs and LDH leakage in control blood platelets were assumed as 100%; (<italic>n</italic> = 7&#x02013;13; <italic>p</italic> &#x0003e; 0.05).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Pulmonaria</italic> Phenolic-Rich Fraction Concentration [&#x000b5;g/mL]</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Viability of PBMCs Based on Propidium Iodide Assay</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Viability of PBMCs Based on Resazurin Reduction Assay</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% of LDH Leakage from Blood Platelets</th></tr></thead><tbody><tr><td rowspan="5" align="center" valign="middle" colspan="1">
<italic>P. obscura</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">102.15 &#x000b1; 13.12</td><td align="center" valign="middle" rowspan="1" colspan="1">96.84 &#x000b1; 8.70</td><td align="center" valign="middle" rowspan="1" colspan="1">100.55 &#x000b1; 9.04</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">106.80 &#x000b1; 6.21</td><td align="center" valign="middle" rowspan="1" colspan="1">94.59 &#x000b1; 8.14</td><td align="center" valign="middle" rowspan="1" colspan="1">99.67 &#x000b1; 12.50</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">100.11 &#x000b1; 9.78</td><td align="center" valign="middle" rowspan="1" colspan="1">95.25 &#x000b1; 8.68</td><td align="center" valign="middle" rowspan="1" colspan="1">101.16 &#x000b1; 11.22</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">50</td><td align="center" valign="middle" rowspan="1" colspan="1">105.45 &#x000b1; 6.52</td><td align="center" valign="middle" rowspan="1" colspan="1">98.53 &#x000b1; 11.10</td><td align="center" valign="middle" rowspan="1" colspan="1">97.86 &#x000b1; 6.98</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">100.21 &#x000b1; 12.08</td><td align="center" valign="middle" rowspan="1" colspan="1">93.75 &#x000b1; 8.69</td><td align="center" valign="middle" rowspan="1" colspan="1">94.92 &#x000b1; 6.84</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>P. officinalis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">102.97 &#x000b1; 9.32</td><td align="center" valign="middle" rowspan="1" colspan="1">93.71 &#x000b1; 8.10</td><td align="center" valign="middle" rowspan="1" colspan="1">103.30 &#x000b1; 13.33</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">106.66 &#x000b1; 7.05</td><td align="center" valign="middle" rowspan="1" colspan="1">93.76 &#x000b1; 10.54</td><td align="center" valign="middle" rowspan="1" colspan="1">105.59 &#x000b1; 15.16</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">104.18 &#x000b1; 10.77</td><td align="center" valign="middle" rowspan="1" colspan="1">93.59 &#x000b1; 9.32</td><td align="center" valign="middle" rowspan="1" colspan="1">102.32 &#x000b1; 7.57</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">50</td><td align="center" valign="middle" rowspan="1" colspan="1">104.67 &#x000b1; 9.15</td><td align="center" valign="middle" rowspan="1" colspan="1">96.70 &#x000b1; 7.51</td><td align="center" valign="middle" rowspan="1" colspan="1">98.68 &#x000b1; 13.30</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">107.05 &#x000b1; 5.53</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97.33 &#x000b1; 9.43</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.65 &#x000b1; 7.67</td></tr></tbody></table></table-wrap><table-wrap id="molecules-26-00631-t008" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00631-t008_Table 8</object-id><label>Table 8</label><caption><p>Summary of computational analysis of the most abundant compounds found in <italic>P. obscura</italic> and <italic>P</italic>. <italic>officinalis</italic>. MW&#x02013;predicted molecular weight, MBS, HA&#x02013;the number of heavy atoms, PI&#x02013;Protease inhibitor Molinspiration bioactivity score v2014.03, MBS EI&#x02013;Enzyme inhibitor Molinspiration bioactivity score v2014.03, &#x00394;G&#x000b0;&#x02013;predicted standard free energy of ligand binding, LE-Ligand Efficiency (LE = &#x02013;RTlnK<sub>d</sub>/HA or &#x02013;&#x00394;G&#x000b0;/HA), LELP = milog P/LE. The most probable inhibitors and indomethacin are marked in bold. Locations of docking of two the most potent COX inhibitors, i.e., menisdaurin and salvianolic acid H as well as indomethacin (a reference COX inhibitor) are visualized in <xref ref-type="fig" rid="molecules-26-00631-f003">Figure 3</xref>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">(No.)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound Names, Chemical Formula and SMILES</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">~MW (Da)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">H.A.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">milogP</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MBS PI</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MBS EI</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x00394;G&#x000b0;<italic><sub>bind</sub></italic> (kcal/mol) COX2</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">LE<break/>LELP</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>4</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>2&#x02013;O&#x02013;<italic>E</italic>&#x02013;caffeoyl&#x02013;<sc>l</sc>&#x02013;threonic acid</bold><break/>O=C(C=Cc1ccc(O)c(O)c1)O[C@H](C(=O)O)[C@@H](O)CO</td><td align="center" valign="middle" rowspan="1" colspan="1">298</td><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.49</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.34</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.6 &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.36<break/>&#x02013;1.36</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>1</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">Danshensu<break/>c1(ccc(c(c1)O)O)C[C@@H](O)C(=O)O</td><td align="center" valign="middle" rowspan="1" colspan="1">198</td><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.27</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.8 &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.49<break/>&#x02013;0.51</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>6</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Chlorogenic acid</bold><break/>O=C(C=Cc1ccc(O)c(O)c1)O[C@@H]2C[C@](O)(C(=O)O)C[C@@H](O)[C@H]2O</td><td align="center" valign="middle" rowspan="1" colspan="1">354</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.45</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.25</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.62</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.9 &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.32<break/>&#x02013;1.41</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>37</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Globoidnan A</bold><break/>c1(cc2cc(c(cc2c(c1)c1ccc(c(c1)O)O)O)O)C(=O)O[C@@H](C(=O)O)Cc1ccc(c(c1)O)O</td><td align="center" valign="middle" rowspan="1" colspan="1">492</td><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">3.12</td><td align="center" valign="middle" rowspan="1" colspan="1">0.11</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.26</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.7 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.24<break/>13.00</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>18</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Globoidnan B</bold><break/>O([C@H](Cc1cc(c(cc1)O)O)C(=O)O)C(=O)c1c(c(c2c(c1)cc(c(c2)O)O)c1cc(c(cc1)O)O)C(=O)O</td><td align="center" valign="middle" rowspan="1" colspan="1">537</td><td align="center" valign="middle" rowspan="1" colspan="1">39</td><td align="center" valign="middle" rowspan="1" colspan="1">2.28</td><td align="center" valign="middle" rowspan="1" colspan="1">0.09</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.28</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.9 &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.18<break/>12.67</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>31</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Lithospermic acid A</bold><break/>c12[C@@H]([C@@H](Oc1c(ccc2/C=C\C(=O)O[C@@H](Cc1cc(c(cc1)O)O)C(=O)O)O)c1cc(c(cc1)O)O)C(=O)O</td><td align="center" valign="middle" rowspan="1" colspan="1">539</td><td align="center" valign="middle" rowspan="1" colspan="1">39</td><td align="center" valign="middle" rowspan="1" colspan="1">1.57</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.28</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.8&#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.20<break/>7.85</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>2</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Menisdaurin</bold><break/>O1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1O[C@H]1/C(=C\C#N)/C=C[C@H](C1)O)O)O)O)CO</td><td align="center" valign="middle" rowspan="1" colspan="1">313</td><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.79</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.28</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.91</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.2 &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.28<break/>&#x02013;6.39</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>29</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Monardic acid A</bold><break/>O1[C@@H]([C@H](c2c1c(ccc2/C=C/C(=O)O[C@@H](Cc1cc(c(cc1)O)O)C(=O)O)O)C(=O)O)c1cc(c(cc1)O)O</td><td align="center" valign="middle" rowspan="1" colspan="1">539</td><td align="center" valign="middle" rowspan="1" colspan="1">39</td><td align="center" valign="middle" rowspan="1" colspan="1">1.57</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.28</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.6 &#x000b1; 0.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.20<break/>7.85</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>27</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Rosmarinic acid</bold><break/>[C@@H](C(=O)O)(OC(=O)/C=C/c1ccc(c(c1)O)O)Cc1ccc(c(c1)O)O</td><td align="center" valign="middle" rowspan="1" colspan="1">360</td><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">1.53</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.24</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.3 &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.32<break/>4.78</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>23</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Quercetin 3&#x02013;<italic>O</italic>&#x02013;(6&#x02019;&#x02019;&#x02013;<italic>O</italic>&#x02013;malonyl)&#x02013;</bold><bold>&#x003b2;&#x02013;glucoside</bold><break/>O1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1Oc1c(oc2c(c1=O)c(cc(c2)O)O)c1cc(c(cc1)O)O)O)O)O)COC(=O)CC(=O)O</td><td align="center" valign="middle" rowspan="1" colspan="1">550</td><td align="center" valign="middle" rowspan="1" colspan="1">39</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.66</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.35</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.3 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.16<break/>&#x02013;4.13</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>26</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">Shimobashiric acid C<break/>[C@@H]1([C@@H]([C@@H]([C@H]1c1cc(c(cc1)O)O)C(=O)O[C@@H](C(=O)O)Cc1cc(c(cc1)O)O)c1cc(c(cc1)O)O)C(=O)O[C@@H](C(=O)O)Cc1cc(c(cc1)O)O</td><td align="center" valign="middle" rowspan="1" colspan="1">721</td><td align="center" valign="middle" rowspan="1" colspan="1">52</td><td align="center" valign="middle" rowspan="1" colspan="1">2.98</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.52</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.21</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.6 &#x000b1; 0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07<break/>42.57</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>33</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Salvianolic acid H</bold><break/>O([C@H](Cc1cc(c(cc1)O)O)C(=O)O)C(=O)/C=C/c1c(c(c(cc1)O)O)/C=C/c1cc(c(cc1)O)O</td><td align="center" valign="middle" rowspan="1" colspan="1">495</td><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">3.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.21</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.8 &#x000b1; 0.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.24<break/>12.54</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>22</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">Yunnaneic acid E<break/>[C@@H]1([C@H](C(=C[C@H]([C@@H]1c1ccc(c(c1)O)O)C(=O)O)/C=C/C(=O)O[C@@H](C(=O)O)Cc1ccc(c(c1)O)O)C(=O)O)C(=O)O</td><td align="center" valign="middle" rowspan="1" colspan="1">573</td><td align="center" valign="middle" rowspan="1" colspan="1">41</td><td align="center" valign="middle" rowspan="1" colspan="1">1.03</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.7 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19<break/>5.42</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>36</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">Yunnaneic acid B<break/>O1[C@]2([C@@](O[C@@]31[C@H]1[C@@H]([C@H]([C@@H](C3=O)[C@H](C1)CCC(=O)O[C@@H](C(=O)O)Cc1cc(c(cc1)O)O)C(=O)O)c1cc(c(cc1)O)O)([C@H]1[C@@H]([C@H]([C@@H]2[C@H](C1)/C=C/C(=O)O[C@@H](C(=O)O)Cc1cc(c(cc1)O)O)C(=O)O)c1cc(c(cc1)O)O)O)O</td><td align="center" valign="middle" rowspan="1" colspan="1">1001</td><td align="center" valign="middle" rowspan="1" colspan="1">79</td><td align="center" valign="middle" rowspan="1" colspan="1">1.95</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.72</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.78</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;10.2 &#x000b1; 0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13<break/>15</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Indomethacin</bold><break/>C(=O)(n1c(C)c(c2cc(ccc12)OC)CC(=O)O)c1ccc(Cl)cc1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">358</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>0.30</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;9.4 &#x000b1; 1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.38<break/>10.50</td></tr></tbody></table></table-wrap></floats-group></article>